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ABSTRACT 
 Preterm birth is a leading cause of infant mortality and morbidity. Increased 
understanding of the etiology of preterm birth is needed to accelerate medical and public 
health interventions. Parturition is associated with markers of the damaging effects of 
reactive oxygen species (ROS). Whereas roles for prostaglandins, cytokines, and 
apoptosis in parturition have been described, the effect of ROS on these parturition 
pathways is unclear. Using the human placental trophoblast cell line HTR-8/SVneo, we 
investigated the effect of the lipophilic ROS-producing chemical tert-butyl 
hydroperoxide (TBHP) on trophoblast apoptosis, prostaglandin production, and cytokine 
release.  
Exposure to TBHP stimulated significant, though modest, increases in redox-
related responses including production of ROS, glutathione redox potential (Eh), reporter 
activity at the antioxidant response element (ARE), and expression of the antioxidant 
genes thioredoxin reductase 1 and glutaredoxin 2. Under our treatment conditions, TBHP 
significantly increased caspase 3/7 activity and decreased cell viability, indicative of 
apoptosis. Apoptotic responses were inhibited by the iron-chelating antioxidant, 
deferoxamine. Likewise, TBHP stimulated release of prostaglandin E2 (PGE2) and 
mRNA expression of prostaglandin-endoperoxide synthase 2 (PTGS2), an enzyme in the 
prostaglandin synthetic pathway. In addition, TBHP increased release of the cytokine 
interleukin-6 (IL-6) and reporter activity of the proinflammatory transcription factor 
nuclear factor-kappaB (NF-kappaB). Cotreatment with the PTGS inhibitor indomethacin 
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or the antioxidants butylated hydroxyanisole (BHA) and diphenyl phenylenediamine 
(DPPD) blocked the TBHP-stimulated PGE2 response. Similarly, TBHP-stimulated IL-6 
release was blocked by the antioxidants BHA, DPPD, and deferoxamine.  
We next examined the redox-sensitive mitogen activated protein kinases 
(MAPKs) as an upstream pathway for the TBHP-stimulated responses. Treatment with 
TBHP increased phosphorylation of p38 MAPK, indicative of activation, and 
pretreatment with the p38 MAPK inhibitor PD169316 blocked the TBHP-stimulated 
increases in IL-6 as well as PGE2 and PTGS2, suggesting dependence of these responses 
on p38 MAPK activity.  
In summary, these results suggest that exposure to an ROS-producing chemical 
stimulates responses in human placental cells linked to parturition. Because exposure to 
some environmental pollutants causes cellular ROS formation, these findings suggest a 
plausible mechanism that may underlie associations between pollutant exposures and 
increased risk for preterm birth. 
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CHAPTER 1  
INTRODUCTION 
Preterm birth – a significant public health problem 
Birth that is preterm, or before 37 weeks of gestation, results in sequelae that 
include delayed cognitive development (Colvin et al. 2004), pulmonary deficiencies 
(Baraldi and Filippone 2007), sensory impairments (Colvin et al. 2004), and behavioral 
disorders (Johnson 2007; Saigal and Doyle 2008). Furthermore, complications, such as 
those of impaired cognition, can persist into adulthood (Hack 2009). Preterm birth also is 
the leading cause of infant mortality: over one-third of infant deaths in the United States 
can be attributed to preterm birth (Callaghan et al. 2006). Moreover, preterm birth is 
prevalent: in 2010, over 475,000 infants were born preterm, accounting for 12.0% of all 
deliveries (Martin et al. 2012). In addition to its effect on the public health, early birth is 
also costly to society. In 2005, the economic cost of preterm birth was estimated at over 
$26 billion annually (Behrman and Butler 2007). With the exception of progesterone 
administration (Merlob et al. 2012), clinical interventions to prevent preterm birth have 
proven largely unsuccessful, in part due to of a lack of understanding about the etiology 
of preterm birth (Behrman and Butler 2007). In 2007, the Institute of Medicine released a 
report recommending more research to understand mechanisms involved in the 
pathogenesis of preterm birth and thusly accelerate development of measures to avoid 
preterm birth (Behrman and Butler 2007). 
 2 
Parturition 
Parturition is characterized by three major physiologic events: coordinated 
myometrial contractions, cervical ripening, and rupture of the extraplacental membranes 
(Figure 1.1). Two biochemical mediators, matrix metalloproteinases (MMPs) and 
prostaglandins, are largely responsible for driving the events of labor. Matrix 
metalloproteinases are protease enzymes whose collagenolytic activity is involved in a 
variety of biological processes including cellular migration (Librach et al. 1991), 
activation of cytokines (D'Haese 2000; Van den Steen et al. 2000), and unmasking of 
ligands that initiate apoptosis (Kayagaki et al. 1995). During parturition, MMP protease 
activity degrades the extracellular matrix of the cervix and membranes leading to 
softening of the cervix and membrane ruptures (Gonzalez et al. 2011; Uchide et al. 2000).  
Prostaglandins are lipid-signaling molecules that elicit a variety of functions 
including regulation of vascular tone (Félétou et al. 2011), pulmonary smooth muscle 
tone (Tilley et al. 2003), and platelet aggregation (Kuriyama 2010). Prostaglandins are 
produced by a series of step-wise biochemical reactions. First, arachidonic acid is 
released from the phospholipid bilayer by phosphoplipase A2 (PLA2) (Balsinde et al. 
1999). Arachidonic acid is then metabolized by prostaglandin endoperoxide synthase 
(PTGS, also known as cyclooxygenase) to produce prostaglandin H2 (PGH2) 
(Chandrasekharan and Simmons 2004). Finally, prostaglandins are further isomerized by 
respective prostaglandin synthases. In the case of the bioactive prostaglandin PGE2, 
PGH2 is isomerized by prostaglandin E synthase (PTGES) to produce PGE2 (Park et al. 
2006). Prostaglandins can be further catabolized to biologically inactive keto-metabolites 
by 15-hydroxyprostaglandin dehydrogenase (HPGD) (Tai et al. 2006). Of relevance to 
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this dissertation, prostaglandins initiate myometrial contractions during parturition (Bailie 
et al. 2002; Parkington et al. 1999). 
Preterm labor occurs with untimely activation of the pathways that generate 
mediators of normal term parturition (Behrman and Butler 2007). The placenta and 
extraplacental membranes, composed of amnion, chorion laeve, and decidua (Figure 1.1), 
are important sources for production of parturition mediators. For example, increased 
expression of MMP-9 is found in placenta and extraplacental membranes of women in 
both term and preterm labor (Xu et al. 2002). Likewise, expression of PTGS2, a key 
inducible enzyme in the synthesis of prostaglandins, is increased during labor at term or 
preterm in placenta (Cindrova-Davies et al. 2007; Hanna et al. 2006) and extraplacental 
membranes (Mijovic et al. 1998; Slater et al. 1998). 
Inflammation and parturition 
In addition to production of parturition-driving MMPs and prostaglandins, the 
placenta and extraplacental membranes are important sources of proinflammatory 
cytokines. During labor, the amnion and choriodecidua produce the cytokines interleukin 
(IL)-6 (Laham et al. 1996) and IL-1β (Elliott et al. 2001). Similarly, tumor necrosis factor 
(TNF)-α, IL-1β, (Cindrova-Davies et al. 2007b), and IL-6 (Steinborn et al. 1998) are also 
increased in placenta during labor. Importantly, these inflammatory cytokines initiate 
production of the parturition-promoting MMPs and prostaglandins, and the subsequent 
events of parturition (Romero et al. 2007). For example, exposure of extraplacental 
membranes to TNFα and IL-1β stimulates MMP-9 expression and decreases tensile 
strength of the tissue (Kumar et al. 2006). In addition, the cytokines TNFα, IL-1β, or IL-6 
stimulate PGE2 release from human amnion cells (Furuta et al. 2000). Further implicating 
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inflammatory pathways in labor initiation, administration of IL-1β to pregnant mice 
induces premature labor (Romero et al. 1991), while knockout of IL-6 in mice delays 
normal labor in mice (Robertson et al. 2010).  
Inflammation due to infectious agents stimulates preterm birth. In point of fact, as 
many as 25-40% of preterm births can be attributed to intrauterine infection (Goldenberg 
and McClure 2010). Pregnancies complicated with bacterial vaginosis (Flynn 1999; 
Leitich et al. 2003) or intrauterine infection (Goldenberg et al. 2008; Romero et al. 2007) 
are at increased risk of preterm birth. Furthermore, administration of lipopolysaccharide 
(LPS) to pregnant mice stimulates early parturition (Elovitz et al. 2003; Kaga et al. 1996). 
Mechanistically, bacterial products, including LPS, engage toll-like receptors (TLRs) on 
the surface of the cell to stimulate cytokine production (Romero et al. 2007) that then 
signal to downstream labor effectors, inducing parturition (Figure 1.1).  
Inflammation, signal transduction, and transcription factors 
The mitogen activated protein kinases (MAPKs) are a prototypical class of signal 
transducers that regulate a wide variety of cellular functions (Zhang and Dong 2005). 
Three common pathways exist in mammals: extra-cellular signal-regulated protein 
kinases (ERKs), c-Jun NH2-terminal kinases (JNKs), and p38 MAPK. Activation of 
MAPKs initiates inflammatory responses in a number of tissue and cell types (Zhang and 
Dong 2005), including human gestational tissues. MAPK pathway activity is required for 
cytokine, prostaglandin, and MMP release following stimulation of trophoblast, 
myometrium, and the extraplacental membranes with LPS or inflammatory cytokines 
(Bartlett et al. 1999; Lappas et al. 2007; Li et al. 2010; Renaud et al. 2009; Sooranna et 
al. 2005). 
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Similarly, nuclear factor-κB (NF-κB) transcriptional activity is required in many 
inflammatory processes (Vallabhapurapu and Karin 2009), including induction of 
parturition-promoting mediators in gestational tissues (Lappas and Rice 2007). The 
family of NF-κB transcription factors consists of five members: RelA, c-Rel, and RelB, 
which contain transcriptional activation domains. The remaining two members, NF-κB1 
and NF-κB2, do not contain said domains. In unstimulated cells, inactive NF-κB is 
sequestered into the cytoplasm by inhibitor of κB (IκB). Upon exposure to various 
stimuli, IκB is degraded and NF-κB dimers are free to translocate to the nucleus where 
they activate transcription (Vallabhapurapu and Karin 2009). Inhibition of NF-κB activity 
prevents proinflammatory cytokine- and LPS-induced increases in cytokine release and 
prostaglandin synthesis in cultured gestational membrane cells and tissues (Ackerman et 
al. 2008; Keelan et al. 2009; Lappas et al. 2002) and delays labor onset in mice (Condon 
et al. 2004). Furthermore, nuclear translocation of RelA (also known as p65) in fetal 
membranes is increased in laboring women compared to non-laboring women (Vora et al. 
2010). 
Reactive oxygen species and parturition  
Parturition is associated with biomarkers indicating cellular and tissue damage 
owing to reactive oxygen species (ROS). The ROS include the oxygen-containing 
radicals superoxide and hydroxyl radical, and the non-radical hydrogen peroxide, among 
others. Hallmark indicators of cellular oxidative damage include lipid peroxidation, 
protein carbonyl formation, and oxidation of DNA bases. Women in labor at term have 
increased cord blood levels of malondialdehyde (MDA) (Mocatta et al. 2004; Yaacobi et 
al. 1999) and lipid hydroperoxides (Mongelli et al. 1997; Rogers et al. 1998). Term 
parturition is also associated with increased maternal blood MDA (Nakai et al. 2000) and 
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susceptibility of maternal serum to lipid oxidation (Fainaru et al. 2002). Labored placenta 
exhibits increased lipid peroxidation (Diamant et al. 1980), 8-isoprostanes, 8-
hydroxydeoxyguanosine (8-OHdG) (Hung et al. 2011), and hydroxynonenal (Cindrova-
Davies et al. 2007b), all markers for the damaging effects of ROS.  
In addition to association with term labor, markers for cellular damage due to 
ROS have been associated with adverse pregnancy outcomes. For example, preeclampsia 
is associated with protein nitrotryosine, malondialdehyde, and lipid hydroperoxides in the 
placenta (Hubel 1999). Besides preeclampsia, increased urinary excretion of 8-OHdG at 
midgestation is associated with shortened gestation length (Stein et al. 2008). The 
damaging effects of ROS also appear to be increased in preterm deliveries compared with 
term deliveries. One study found increased MDA in cord blood of preterm deliveries, but 
also found decreased protein carbonyl content (Mocatta et al. 2004), whereas a second 
study reported that protein carbonyl content, as well as MDA, were increased maternal 
and cord blood of preterm deliveries (Pathak et al. 2010). Furthermore, total placental 
isoprostanes are increased in preterm deliveries compared with term deliveries (Comporti 
et al. 2004). 
Given the association between ROS and labor, it is important to understand 
whether ROS may be playing a mechanistic role in the activation of parturition-
promoting pathways within the gestational compartment. However, there are rather few 
studies to implicate that ROS may be involved in mediating the events of labor. In mice, 
administration of the antioxidant N-acetylcysteine (NAC) blocks LPS-induced premature 
delivery (Buhimschi et al. 2003), and treatment of pregnant rats with diphenyl 
phenylenediamine (DPPD), another antioxidant, significantly increases gestation length 
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(Matsumoto et al. 2013). In human tissues, NAC blocks LPS-stimulated cytokine 
production from extraplacental membrane explants in vitro (Lappas et al. 2003). 
Reactive oxygen species and cellular signaling transduction relevant to parturition 
In addition to damaging effects on cellular constituents, ROS also act as signal 
transduction mediators (Nathan 2003; Paulsen and Carroll 2009; Reth 2002). For 
example, ROS may oxidize thiolate anions located on the cysteine residues of proteins. 
Similar to other types of posttranslational modifications like phosphorylation, cysteine 
oxidation can vastly affect protein function (Reth 2002). For instance, oxidation of 
cysteine resides within the catalytic domains of phosphatases blocks phosphatase activity. 
Inhibition of phosphatase results in dysregulation of MAPK phosphorylation and activity 
(Salmeen 2005). Several lines of evidence suggest that ROS may act as signal 
transduction mediators in inflammatory pathways. For example, exposure of T cells 
directly to hydrogen peroxide induces activation of NF-κB (Schreck et al. 1991). In 
addition, many antioxidants are also anti-inflammatory agents: N-acetyl cysteine and α-
tocopherol block LPS-stimulated production of cytokines and nuclear translocation of 
NF-κB in rat Kupffer cells (Fox et al. 1997). Moreover, exposure of cells to pro-
inflammatory stimuli induces production of ROS via the enzyme NADPH oxidase (Rhee 
et al. 2003). As such, ROS at the maternal-fetal interface may stimulate production of 
parturition-promoting inflammatory pathways involving prostaglandins and cytokines. 
Tert-butyl hydroperoxide as a model ROS-producing chemical 
A variety of methods can be used to generate ROS in vitro in studies of 
gestational cells. For example, cells from the amnion have been treated with hydrogen 
peroxide (Kumar et al. 2004a; Kumar et al. 2004b), and myometrial cells have been 
treated with xanthine oxidase to produce superoxide (Warren et al. 2005). In addition, 
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placental explants have been exposed to hypoxia-reoxygenation (Hung et al. 2001; 
Cindrova-Davies et al. 2007a), which also generates ROS. Unlike glucose oxidase- and 
xanthine oxidase-containing model systems that utilize enzymatic reactions to generate 
ROS extracellularly, TBHP is lipid soluble and passes the plasma membrane and to enter 
cells (Ahmed-Choudhury et al. 1998). Principally, TBHP produces tert-butyl alkoxyl and 
tert-butyl peroxyl radicals in a series of iron-catalyzed reactions similar to the Fenton and 
Haber-Weiss reactions (Huang et al. 2005; Figure 1.2). These alkoxyl and peroxyl 
radicals may go on to react with cellular constituents, producing alterations in signal 
transduction or even cellular damage. In addition to direct, iron-catalyzed formation of 
ROS, TBHP may also indirectly shunt the cell towards production of ROS. As a 
hydroperoxide, TBHP is a substrate for the metabolizing enzyme glutathione peroxidase 
(Eklow et al. 1984; Huang et al. 2005). Using the cellular thiol glutathione (GSH) as a 
cofactor, TBHP is converted to tert-butyl alcohol by glutathione peroxidase (Figure 1.2). 
By effectively depleting cellular stores of GSH, TBHP diminishes the cellular reducing 
capacity. As a result, additional ROS produced by TBHP or other cellular processes may 
not be scavenged, and are thus free to react with further cellular constituents including 
lipids, proteins, or DNA. TBHP is commonly used as a model to study the effect of ROS 
on cellular functions. Moreover, recently, the Environmental Protection Agency released 
a report suggesting that a breakdown product of TBHP, tert-butyl alcohol, may be 
contaminating water near hydraulic fracturing sites (DiGiulio et al. 2011). The extent and 
health effects of human exposure to TBHP or its breakdown products in contaminated 
waters are unclear.  
The HTR-8/SVneo cell line as a model for in vitro study of placental cell responses 
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 The HTR-8/SVneo cell line was derived from first trimester human extravillous 
trophoblast cells and immortalized using the SV40 T antigen (Graham et al. 1993). These 
cells are phenotypically similar to extravillous trophoblasts in that they migrate in 
response to cytokines (Jovanović and Vićovac 2009; Jovanović et al. 2010) and 
prostaglandins (Nicola et al. 2005). However some differences between the epigenetic 
profiles of the cell line and primary cells have been noted (Novakovic et al. 2011). 
Because HTR-8/SVneo cells are easily available and widely studied, many aspects of 
their physiology have been described. In addition, the extravillous trophoblast cell may 
be an important target in dysfunctional pregnancies: it is well-established that aberrant 
extravillous trophoblast migration and spiral artery transformation are associated with 
preeclampsia (Merviel et al. 2004; Wang et al. 2009), and similar pathologies have been 
identified in the placental bed of preterm pregnancies (Kim et al. 2002; Kim et al. 2003). 
HTR-8/SVneo cells have also been used in several previous studies to elucidate 
mechanisms of signaling related to parturition (Allen et al. 2013; Wang et al. 2004; Wang 
et al. 2007).  
Environmental exposures and risk for preterm labor 
Limited studies suggest that environmental exposures may increase risk for 
preterm labor (see Ferguson et al. 2013 for a comprehensive review). For example, 
cigarette smokers are more likely to deliver preterm (Cnattingius 2004) and have 
increased systemic markers for the damaging effects of ROS and inflammation 
(Yanbaeva et al. 2007). Similarly, increased organochlorine pesticide exposures are 
associated with increased markers for ROS and increased rates of preterm delivery 
(Pathak et al. 2010). Other exposures, including lead and phthalates, have also been 
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associated with increased risk for preterm birth (Jelliffe-Pawlowski et al. 2006; Torres-
Sánchez et al. 1999; Dietrich 1991; Meeker et al. 2009), and increased generation of ROS 
in various tissues (Ercal et al. 2001; Ferguson et al. 2011; Jomova and Valko 2011; 
Kasahara et al. 2002; Liu et al. 2010; Seo et al. 2004; Tetz et al. 2013). Because pregnant 
women are exposed to many chemicals through the ambient, home, and work 
environments, an improved understanding of environmental chemical impacts on 
gestational tissues is warranted. 
Hypothesis 
Damage due to ROS is associated with preterm birth, and ROS can act as 
signaling molecules to mediate inflammatory-type pathways important for parturition. 
Therefore this dissertation characterizes the mechanistic relationship between ROS and 
parturition-associated mediators. We hypothesize that reactive oxygen species 
stimulate parturition mediators including prostaglandins, cytokines, and apoptotic 
caspases in human gestational cells and tissues. To test this hypothesis, we used the 
prototypical pro-oxidant chemical tert-butyl hydroperoxide (TBHP) and the human 
placental trophoblast cell line HTR-8/SVneo. The specific aims of this dissertation are to: 
1) demonstrate that TBHP stimulates cellular apoptosis; 2) demonstrate that TBHP 
stimulates prostaglandin production; 3) demonstrate that TBHP stimulates release of the 
parturition-associated cytokine IL-6 following exposure to TBHP in a human placental 
trophoblast cell line, HTR-8/SVneo. This dissertation is the first series of studies to 
examine the effect of low dose chemical oxidant on the parturition-specific mediators IL-





Figure 1.1. The pregnant uterus and parturition. Cytokines, including IL-1β, TNFα, 
and IL-6, stimulate synthesis of biochemical mediators prostaglandins, PGE2 and PGF2α, 
and MMPs, MMP-2 and MMP-9. These biochemical mediators then drive the events of 
labor: rupture of the extraplacental membranes, contractions of the myometrium, and 





























Figure 1.2. Generation of free radicals by TBHP.  Tert-butyl hydroperoxide (TBHP; t-
bu-OOH) produces tert-butyl alkoxyl radical (t-buO) in reaction with ferrous iron (Fe2+). 
Ferric iron (Fe3+) reacts with TBHP to produce tert-butyl peroxyl radical (t-buOO). 
Resultant peroxyl and alkoxyl radicals may then react with cellular constituents including 
DNA, protein, or lipids to produce alkyl radicals (R). Because it is a hydroperoxide, 
TBHP is as a substrate for glutathione peroxidase (Gpx). Gpx converts TBHP to tert-
butyl alcohol (t-buOH), in concert with oxidation of two glutathione (GSH) molecules to 
one glutathione disulfide (GSSG). Glutaredoxin (GRx) catalyzes the reduction of 
oxidized GSSG to GSH using NADPH as an electron donor. Image modified from Huang 
et al. 2005.   
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CHAPTER 2  
PLACENTAL CELL LINE APOPTOSIS IN RESPONSE TO TERT-BUTYL 
HYDROPEROXIDE  
INTRODUCTION 
Preterm birth increases risk for neonatal morbidity (Callaghan et al. 2006) and 
mortality (Saigal and Doyle 2008). Cellular damage due to reactive oxygen species 
(ROS) has been associated with both preterm and term labor. Maternal urinary excretion 
of 8-hydroxydeoxyguanosine (8-OHdG), a marker for oxidative DNA damage, is 
associated with decreased gestation length (Stein et al. 2008). In addition, maternal blood 
and cord blood of preterm deliveries have increased malondialdehyde (MDA), indicating 
lipid peroxidation, and protein carbonyl content, a marker for protein oxidation, 
compared with women who labor at term (Pathak et al. 2010). Women in labor at term 
also have increased cord blood levels of MDA (Mocatta et al. 2004; Yaacobi et al. 1999) 
and lipid hydroperoxides (Mongelli et al. 1997) (Rogers et al. 1998). 
In 2007 the Institute of Medicine released a report recommending that 
mechanistic studies are needed order to understand how the environment may be 
contributing to preterm birth (Behrman and Butler 2007). Several environmental 
chemicals have been linked to preterm birth, including organchlorine pesticides (Pathak 
et al. 2010), lead (Jelliffe-Pawlowski et al. 2006), and cigarette smoke (Cnattingius 
2004). Because these chemicals also stimulate ROS in vivo (Pathak et al. 2010; Ahmed et 
al. 2008; Banerjee et al. 2001; Siddharth et al. 2012; Ercal et al. 2001; Jomova and Valko 
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2011; Liu et al. 2010; van der Vaart et al. 2004; Yanbaeva et al. 2007), we hypothesized 
that ROS may be playing a role in modulating the activation of pathways that drive 
parturition.  
Apoptosis within the gestational compartment is associated with parturition; 
increases in placental trophoblast apoptosis has been identified in a mouse model of 
premature labor (Kakinuma et al. 1997). Furthermore, chorion trophoblast apoptosis has 
been implicated in fetal membrane weakening (Moore et al. 2006). Linking ROS to 
gestational cell apoptosis, antioxidants inhibit spontaneous chorion trophoblast apoptosis 
in vitro (Ohyama et al. 2001). Although formation of ROS has been linked to trophoblast 
apoptosis in past studies (Cindrova-Davies et al. 2007; Ohyama et al. 2001), there is little 
known about how a chemical oxidant may effect apoptosis pathways in human 
trophoblasts. As such, the objective of this study was to examine the effect of the pro-
oxidant chemical tert-butyl hydroperoxide (TBHP) on apoptosis pathway activation and 
to characterize corresponding changes in redox-sensitive responses in the human 
placental cell line HTR-8/SVneo. 
MATERIALS AND METHODS 
Materials 
We purchased RPMI 1640 medium supplemented with L-glutamine and without 
phenol red, heat-inactivated fetal bovine serum (FBS), penicillin/streptomycin (10,000 
units/mL and 10,000 µg/mL, respectively), 0.25% trypsin-EDTA, Hank’s Balanced Salt 
Solution (HBSS) with calcium and magnesium but without phenol red, Opti-MEM I 
Reduced Serum Medium supplemented with L-glutamine and hydroxyethyl 
piperazineethanesulfonic acid (HEPES) and without phenol red, 10 mM non-essential 
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amino acids in minimal essential medium, and 6-carboxy-2',7'-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) were from Life Technologies 
(Carlsbad, CA). Tert-butyl hydroperoxide (70% in water), deferoxamine mesylate salt, 
dimethyl sulfoxide, indomethacin, sulforaphane, and camptothecin were purchased from 
Sigma-Aldrich (St. Louis, MO). The inhibitor PD169316 was purchased from EMD 
Millipore (Billerica, MA). The inhibitors U0126 and SP600125 were from Enzo Life 
Sciences (Farmingdale, NY). We purchased 6-carboxy-2',7'-dichlorodihydrofluorescein 
diacetate (carboxy-H2DCFDA) from Molecular Probes, Life Technologies (Carlsbad, 
CA). Antioxidant Response Cignal reporter assay kit, Attractene transfection reagent, 
QIAshredder columns, and RNeasy kits were purchased from Qiagen (Germantown, 
MD). Dual Luciferase, Caspase-Glo 3/7, and CellTiter-Glo luminescent assays were 
purchased from Promega (Madison, WI). We purchased iScript cDNA synthesis kits and 
SsoAdvanced SYBR Green Supermix from Bio-Rad (Hercules, CA). Primers were 
synthesized by Integrated DNA Technologies (Coralville, IA). 
Cell culture and treatments 
The HTR-8/SVneo cell line was utilized to study placental cell responses to ROS. 
HTR-8/SVneo cells are human extravillous trophoblast cells derived from first trimester 
placentae and were kindly provided as a gift from Dr. Charles H. Graham (Graham et al. 
1993), Queen’s University, Kingston, Ontario, Canada. HTR-8/SVneo cells between 
passages 73-87 were maintained at 37°C in a humidified incubator with 5% CO2 in RPMI 
1640 medium supplemented with 10% FBS, 100 U/mL penicillin, and 100 µg/mL 
streptomycin for 2-3 days until disaggregated by trypsinization. Unless otherwise noted, 
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HTR-8/SVneo cultures were allowed to reach 70-80% confluence 24 h after subculture 
before initiating an experiment.  
Tert-butyl hydroperoxide was employed as a model pro-oxidant that crosses the 
plasma cell membrane to generate intracellular ROS (Ahmed-Choudhury et al. 1998). To 
treat HTR-8/SVneo cells, culture medium was exchanged with fresh medium containing 
TBHP (diluted directly in medium) or medium alone. For experiments with treatments 
that preceded TBHP exposure, medium was aspirated and cells were pretreated with 1 
mM deferoxamine (DFO; dissolved directly into medium), 0.1% DMSO (vehicle 
control), PD169316, U0126, SP600125, or medium alone. One hour later, medium was 
aspirated, and cells were treated with TBHP or medium alone. For experiments that 
included indomethacin, cells were coexposed to 50 µM TBHP, 0.1% DMSO (vehicle 
control), or 10 µM indomethacin. We chose to treat with 50 µM TBHP because it was the 
effective concentration to elicit cellular responses, including apoptosis and prostaglandin 
(see Chapter 3) and cytokine (see Chapter 4) release. HTR-8/SVneo cells were exposed 
to 10 µM sulforaphane or 4 µM camptothecin as positive controls for Nrf activity 
(Kensler et al. 2013) and caspase activity (Tetz et al. 2013), respectively. 
Caspase 3/7 Activity Assay 
Caspase 3/7 activity was assayed as an indication of activation of the apoptotic 
pathway. HTR-8/SVneo cells were seeded at a density of 10-15,000 cells/well in 96-well 
white, clear bottom plates. Following treatment with TBHP, Caspase-Glo 3/7 reagent was 
added to each well, and incubated for 1 h at room temperature in the dark. Luminescence 
was read on a GloMax Multi Plus detection system (Promega) using the manufacturer's 
pre-loaded Caspase-Glo assay protocol.   
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Viability Assay 
 Cellular viability was assessed using the luminescent CellTiter-Glo Assay. In this 
assay, cellular ATP acts as a cofactor in the luciferase reaction to produce light. Thus, the 
amount of output light is proportional to the number of viable cells. HTR-8/SVneo cells 
were seeded at a density of 20,000 cells/well in 96-well white, clear-bottom plates. 
Following treatment of cells with TBHP or positive control (camptothecin), CellTiter-Glo 
reagent was added to wells and plates were mixed briefly on an orbital shaker. The plate 
was incubated at room temperature for 10 min in the dark and then read on a luminometer 
using manufacturer’s programmed settings. 
Measurement of ROS 
 Formation of cellular ROS following treatment with TBHP was assessed by 
dichlorofluorescein (DCF) assay. HTR-8/SVneo cells were seeded in 96-well black, 
clear-bottom plates. Twenty-four hours later, cells were 90-100% confluent and treated 
with 50, 100, or 200 µM TBHP for 2 h in replicates of 5 per treatment. Preliminary 
studies suggested no effect of treatment with lower doses (12.5 or 25 µM TBHP) at this 
treatment duration. Treatments were then removed and cells were washed with HBSS, 
followed by incubation with 100 µM carboxy-H2DCFDA for 1 h at 37°C in HBSS. The 
probe was then removed by gentle aspiration, cells were washed again, and fresh HBSS 
was added to wells. The plate was read immediately from the bottom of the wells using a 
SpectraMax M2e microplate reader (Molecular Devices, Sunnyvale, CA) with excitation 
and emission wavelengths of 492 and 522 nm, respectively.  
Determination of cellular thiol concentrations 
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 TBHP effects on reduced gluathione (GSH) and oxidized glutathione (GSSG) and 
the glutathione redox potential (Eh) were measured in HTR-8/SVneo cells. The cells were 
seeded at a density of 1.5 x 106 in 60 mm dishes. Diluted TBHP was added directly to 
culture medium on the cells in a time-staggered fashion, and all cells were lysed and 
collected at the same time on ice. Cellular GSH concentrations were analyzed by high-
performance liquid chromatography (HPLC) as previously described (Harris and Hansen 
2012). Briefly, the exposure medium was removed, then cells were washed two times 
with ice cold dPBS and lysed in buffer containing 5% perchloric acid, 0.2 M boric acid, 
and 10 µM γ-glutamyl glutamic acid standard. Lysates were collected with scraping, snap 
frozen on liquid nitrogen, and stored at -80°C until analysis. Thawed lysates were 
sonicated, precipitated protein was pelleted by centrifugation, and supernatants were 
transferred to fresh tubes. Samples were derivatized with dansyl chloride at room 
temperature overnight after addition of iodoacetic acid and saturated KOH in KBO4. 
Samples were extracted with chloroform and injected into the HPLC instrument. Protein 
pellets were solubilized and digested with 250 mM NaOH at 4°C overnight. Total protein 
was quantified with the BCA assay. 
Transfections and reporter assays 
Nuclear factor (erythroid-derived 2)-like 2 (Nrf) activity was assessed using a 
commercially available reporter construct (SABiosciences, Qiagen). The reporter consists 
of a mixture of inducible firefly luciferase gene downstream of tandem antioxidant 
response element (ARE) consensus binding site repeats and constitutive Renilla 
luciferase gene controlled by cytomegalovirus (CMV) promoter. Suspensions of 20,000 
HTR-8/SVneo cells were seeded into white, clear bottom 96-well plates containing 
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transfection reagent complexed with negative control, positive control, or ARE reporter 
constructs. Cells were allowed to adhere and transfect for 6 h in the incubator, and an 18-
h recovery period before treating. Cells were then treated with 50 µM TBHP in triplicate 
for 24 h, medium was aspirated, and cells were passively lysed. Dual luciferase assays 
were performed according to manufacturer’s instructions. Luminescence was measured 
using a GloMax Multi Plus detection system (Promega) with two injectors. ARE firefly 
luciferase activity was normalized to luciferase activity of Renilla, included as an internal 
control for cell number and transfection efficiency. Data are presented as the fold change 
in luciferase activity normalized to the control. Cells were maintained in Opti-MEM I 
supplemented with 1% NEAA and 3% FBS throughout the duration of transfection 
experiments.   
RNA isolation and quantitative real-time PCR 
Cells were seeded at a density of 500,000 cells/well in 6-well plates. Following 
removal of culture medium, cells were homogenized using Qiashredder columns, and 
then replicate homogenates were pooled and RNA was extracted using RNeasy columns 
according to manufacturer’s instructions. One microgram of total RNA was reverse 
transcribed using iScript cDNA synthesis kits according to manufacturer’s instructions. 
The following forward and reverse primer sequences were used: beta-2-microglobulin 
(B2M) 5’-TGGAGGCTATCCAGCGTACT-3’ and 5’-CGGATGGATGAAACCCAG 
ACA-3’; glutaredoxin 2 (GLRX2) 5’-TCCTGTTCTTACTGTACAATGGCA-3’ and 5’-
TTGGAACAGTTCTTTCACCAGTC-3’; thioredoxin reductase 1 (TXNRD1) 5’-
CCTGTCTGTGCAGAGGTATTCA-3’ and 5’-TTTGCAGTCTTGGCAACAGC-3’. 
Quantitative RT-PCR reactions were performed on a Bio-Rad CFX Connect Real-Time 
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System or Bio-Rad CFX96 Real-Time System C1000 thermal cyclers according to 
SsoAdvanced SYBR Green Supermix directions. The housekeeping gene B2M was run 
in parallel reactions as a means of normalization. Fold changes in target mRNA 
expression was quantified using the efficiency-corrected ΔΔCt method (Yuan et al. 2006)  
on Bio-Rad CFX manager software. Efficiency was calculated from standard curves run 
in parallel for each experiment. All samples were assayed in triplicate. 
Statistics 
Data were analyzed by matched one or two-way analysis of variance (ANOVA) 
or paired t-tests where appropriate. Statistical analysis was performed using SigmaPlot 
software version 11.0 (Systat Software, Chicago, IL). The qRT-PCR data were analyzed 
using CFX software (Bio-Rad, Hercules, CA). The data subjected to analysis for qRT-
PCR data were ΔCt values (Yuan et al. 2006). 
RESULTS 
Effect of TBHP treatment on HTR-8/SVneo caspase 3/7 activity 
Activity of the effector caspases 3/7 was measured as an indication of apoptosis 
(Slee et al. 2001). Although TBHP exposure failed to stimulate caspase activity at 4 h, 
treatment with 50 µM TBHP for 8 h stimulated a 5.3 fold increase (Figure 2.1A; 
p<0.001), and exposure for 24 h with 25 µM TBHP or 50 µM TBHP stimulated 2.5 fold 
and 5.9 fold increases, respectively, compared to time-matched controls (p<0.05). 
Moreover, the response at 24 h was concentration-dependent, with 50 µM TBHP 
stimulating significantly more activity than 25 µM TBHP (p<0.001). Camptothecin (4 
µM), a positive control for apoptosis, stimulated significant increases over the solvent 
control at 8 and 24 h (p<0.001) to levels similar to those elicited by 50 µM TBHP.  
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To test the hypothesis that TBHP-stimulated caspase activity is dependent on free 
radical formation, cells were pretreated with the iron chelator DFO (1 mM). DFO 
pretreatment significantly decreased TBHP-stimulated caspase activity to levels near 
those of controls at 8 h and 24 h (Figure 2.1B; p<0.001, compared with TBHP alone).  
Cell Viability 
 The effect of TBHP on cellular viability was evaluated using the CellTiter-Glo 
assay for ATP content. Treatment with 12.5, 25, or 50 µM TBHP at 4 and 8 h did not 
significantly affect cell viability (Figure 2.1C). In contrast, concentration-dependent 
decreases in viability of HTR-8/SVneo cells were observed after 24 h of exposure to 25 
and 50 µM TBHP (p<0.05). The positive control treatment with camptothecin (4 µM) 
significantly reduced viability by 48% at 24 h treatment (p<0.001) but not with 4 or 8 h 
of treatment. 
Generation of cellular ROS 
The ROS-sensitive probe DCF was used to evaluate generation of cellular ROS as 
a result of TBHP exposure. Exposure to 200 µM TBHP for 2 h resulted in a significant 
increase of 76% in DCF fluorescence compared to the control (Figure 2.2; p=0.011). 
Exposure to 50 and 100 µM TBHP failed to significantly increase the fluorescent signal.  
TBHP effects on cellular glutathione redox couple 
We examined the cellular redox profile by measuring the concentrations of 
oxidized and reduced GSH, and then using the Nernst equation to derive the GSH/GSSG 
redox potential (Eh). Exposure of HTR-8/SVneo cells to 50 µM TBHP for 15, 30, 45, or 
60 min resulted in no statistically significant alterations of cellular GSH content (Figure 
2.3A). However, treatment for 15 and 30 min increased GSSG concentrations compared 
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with controls by 76% and 62%, respectively (Figure 2.3B; p<0.05). By 45 min of 
exposure, the TBHP-stimulated increase in GSSG was no longer statistically significant, 
although levels still appeared to be elevated. The GSH/GSSG redox potential also 
changed: exposure to TBHP for 15 min significantly increased it by 6.8 mV compared 
with control (Figure 2.3C; p=0.037). No statistically significant changes in the redox 
potential were observed at longer exposure durations with TBHP up to 24 h (data not 
shown).  
ARE reporter activity in response to TBHP 
Activity of the redox sensitive promoter element ARE was assessed in HTR-
8/SVneo cells transfected with an ARE-reporter gene construct. Exposure to 50 µM 
TBHP resulted in increases of 15, 42, and 35% over control at 2, 6, and 8 h, respectively 
(Figure 2.4; p<0.05). Included as a positive control, 10 µM sulforaphane increased ARE 
activity by 41, 71, 91 and 209% over control at 2, 4, 6, and 8 h (p<0.05).  
Antioxidant gene mRNA expression 
We measured TBHP-induced changes in mRNA expression of the antioxidant 
genes TXNRD1 (Nordberg and Arnér 2001) and GLRX2 (Wu et al. 2011), previously 
shown to be induced in HTR-8/SVneo cells by the ROS-stimulating environmental 
chemical mono-2-ethylhexyl phthalate (Tetz et al. 2013). Cells treated with 25 µM TBHP 
for 4 h had a 23% increase in TXNRD1 mRNA expression (Figure 2.5A; p<0.001), 
whereas treatment with 50 µM TBHP stimulated significant increases of 30-44% at 4, 8, 
and 24 h (p<0.05).  Exposure to 50 µM TBHP resulted an increase in GLRX2 mRNA of 
30% at 24 h but not 4 or 8 h compared with time-matched control (Figure 2.5B; p<0.05).  
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DISCUSSION 
Apoptosis, defined as programmed cell death, is characterized by cell membrane 
blebbing and DNA fragmentation (Elmore 2007). Hallmark indicators of cellular 
apoptosis are the activation of the effector caspases 3 and 7, which are responsible for 
protein cleavage that leads to the morphological changes observed during apoptosis 
(Porter and Jänicke 1999; Wyllie 2010). Here, we found that treatment with TBHP 
resulted in robust increases in caspase 3/7 activity and a subsequent decrease in cellular 
viability, suggesting induction of apoptosis.  
Apoptosis of chorionic membrane trophoblasts (Ohyama and Oka 1998), 
placental stromal cells, and placental trophoblasts (Axt et al. 1999; Smith et al. 1997) 
have been reported in human tissues at term. In addition, apoptosis in the extraplacental 
membrane is associated with preterm premature rupture of the membrane (Fortunato et 
al. 2000) and onset of labor at term (Kumagai et al. 2001; Lei et al. 1996). Placental 
trophoblast apoptosis has also been associated with preterm birth (Balkundi et al. 2003; 
Kakinuma et al. 1997). In the chorion, apoptosis is thought to contribute to weakening of 
the extraplacental membranes and subsequent rupture of the membrane (Moore et al. 
2006), whereas in the placenta, it may contribute to placental aging (Smith et al. 1997) 
and parturition (Axt et al. 1999). Here we found that treatment with 50 µM TBHP to 
HTR-8 cells increased caspase 3/7 activity by approximately 5 to 6 fold at 8 and 24 h of 
exposure. Notably, a 3-fold increase in apoptosis has been reported with term labor in 
chorionic trophoblasts (Harirah et al. 2012). Also similar to our study, a 2-fold increase in 
cleaved caspase 3 was observed in placental explants exposed to hypoxia-reoxygenation 
(Cindrova-Davies et al. 2007).  
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Consistent with results reported here, exposure of placental explants to hypoxia-
reperfusion injury results in apoptosis, and the antioxidants vitamin C and E (Cindrova-
Davies et al. 2007) and deferoxamine (Hung et al. 2002) inhibit this response. In the 
present study, treatment with deferoxamine, an iron chelator, blocked the TBHP-
stimulated caspase activity. Because TBHP forms alkoxyl and peroxyl free radicals in 
iron-catalyzed reactions (Van der Zee et al. 1989), inhibition of the apoptotic response by 
deferoxamine suggests that the apoptotic response is dependent on free radical formation. 
Furthermore, we have previously shown that treatment of HTR-8/SVneo cells with 50 
µM TBHP causes formation of oxidized thymine adducts (Tetz et al. 2013), suggesting 
the possibility of DNA damage-induced apoptosis (Wyllie 2010). However, we did not 
detect significantly increased ROS with 50 µM TBHP using the DCF assay, which can 
detect H2O2, hydroxyl, and alkoxyl radicals (Setsukinai et al. 2003), although the DCF 
assay increases were statistically significant with higher concentrations of TBHP. The 
latter finding suggests that the DCF assay may be insensitive for detection of low levels 
of ROS or that there may be an alternative mechanism to explain the inhibition by 
deferoxamine. Further studies, therefore, are needed to examine the role iron plays in 
TBHP-stimulated apoptosis.  
The time-course and magnitude of ROS resulting from TBHP vary widely across 
cell types. Others have reported increases of approximately 1.9-4.5 fold in ROS with cells 
exposed to 50 µM TBHP at similar time points (Sardao et al. 2007; Silva et al. 2010). 
Increases of over 10 fold have been reported in primary rat hepatocytes exposed to 1 mM 
TBHP for 6 h (Perez et al. 2006). Previous studies show that the half-life of TBHP in 
culture (Dringen et al. 1998) and time to ROS formation (Sitozhevsky et al. 1997) occurs 
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quite quickly within cells, suggesting that the lack of ROS detection with 50 µM TBHP 
in the present study may be related to the time point assayed, 2 h. Alternatively, the 
failure to observe ROS with 50 µM TBHP, in contrast to treatment with 200 µM TBHP, 
may reflect a potential lack of sensitivity of DCF assay with this system. Indeed, previous 
studies in our lab have maximally detected increases of approximately 4 fold in DCF 
fluorescence upon treatment of HTR-8/SVneo cells with 180 µM mono-2-ethylhexyl 
phthalate, suggesting detection thresholds may be rather low (Tetz et al. 2013).  
The tripeptide glutathione, the most abundant cellular thiol, plays a critical role in 
regulating the cellular redox homeostasis. Treatment with 50 µM TBHP resulted in no 
significant changes in reduced GSH in the HTR-8/SVneo cells over the time course 
examined. In contrast, in hepatocytes (Buc-Calderon et al. 1991; Martı́n et al. 2001), 
macrophages (Kanupriya et al. 2007), cardiomyocytes, and neuronal cells (Lam et al. 
2011), TBHP induces marked oxidation of GSH. The reported decline in GSH is due, at 
least in part, to the metabolism of TBHP by glutathione peroxidase, with GSH required as 
an electron donor (Eklow et al. 1984). However, TBHP itself has also been reported to 
inhibit glutathione peroxidase activity (Toussaint et al. 1993). Peroxidase activity may be 
blocked by TBHP in HTR-8/SVneo cells, suggesting a possible explanation for the 
difference between studies that have observed decreases in GSH and the present report. 
In addition, we observed that concentrations of GSSG were increased and there was a 
subsequent, though modest, increase of +6.8 mV in the GSH/GSSG reduction potential. 
Typically, apoptosis is induced when the GSH/GSSG reduction potential changes to 
approximately -170 to -150 mV (Harris and Hansen 2012): however, the reduction 
potential at its most oxidizing with TBHP treatment was -227.7 mV. The biological 
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significance of low magnitude changes in the reduction potential is unclear, though it has 
been suggested that even mild changes in the reduction potential may have physiologic 
consequences because of the importance of redox-sensitive protein thiols in cellular 
functions (Dooley et al. 2004). Alternatively, TBHP-induced apoptosis may be occurring 
independently of GSH.  
In addition, we examined TBHP effects on ARE-driven reporter gene expression, 
which can serve as a measure of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 
transcription factor transactivation (Tan et al. 2007). Under reducing conditions, Nrf2 is 
targeted for ubiqutination and subsequent proteasomal degradation by Keap1. Upon 
oxidation or electrophilic attack of sulfhydryl groups on Keap1, Nrf2 then binds ARE and 
drives transcription of for ubiquitination, This response element is found in a number of 
genes, including enzymatic antioxidants (Motohashi and Yamamoto 2004). Notably, 
TBHP stimulated modest increases, less than 50%, in ARE activity. In accordance with 
TBHP-stimulated Nrf2 activation, Nrf2 nuclear translocation has been observed by 
immunofluorescence staining in endothelial cells treated with TBHP (Bitar et al. 2012). 
In contrast, the positive control sulforaphane induced more robust increases of 
approximately 2 fold over an 8 h time course in our study. Similar increases within this 
time course have been observed with sulforaphane in HepG2 cells (Hong et al. 2005) and 
human keratinocytes (Wagner et al. 2010), suggesting that HTR-8/SVneo cells are 
capable of mounting ARE-driven responses. The biological significance of lower-level 
induction of ARE activity in HTR-8/SVneo cells by TBHP is unclear. However, Nrf2 has 
established cytoprotective roles (Baird and Dinkova-Kostova 2011). Therefore, low level 
Nrf2 induction may not have been sufficient overcome the stress and resultant apoptosis 
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exacted by TBHP. Additionally, we also found modest increases in expression of 
transcripts for antioxidant genes TXNRD1 and GLRX2. Because transcription of the 
latter genes is linked to the ARE (Gallogly et al. 2009; Hintze et al. 2003), the modest 
increases in TBHP-stimulated ARE activity are consistent with the relatively low-level 
increases in the TXNRD1 and GLRX2 mRNA responses.  
Compared to the robust increase in TBHP-stimulated caspase 3/7 activity, the 
more direct measures of cellular redox responses (ROS, GSSG, and antioxidant gene 
expression) are consistently modest. There are several possible explanations for these 
findings. First, it is possible that these indices are changing over time, but we have 
missed the window of more robust change. Second, there are a myriad of measures that 
are used to examine cellular responses to ROS, and we may have chosen ones that are not 
responsive to TBHP in this HTR-8/SVneo cell system. For example, because TBHP-
stimulated PGE2 (see Chapter 3) and IL-6 (see Chapter 4) are blocked by antioxidants 
that prevent lipid peroxidation (DPPD and BHA), measures of lipid peroxidation may 
accurately reflect the HTR-8/SVneo response to ROS more accurately. Third, TBHP may 
be stimulating ROS responses that are in fact very modest, and a modest change is 
responsible for driving the TBHP-stimulated downstream effects on apoptosis, 
prostaglandins (see Chapter 3), and cytokines (see Chapter 4). Because TBHP stimulated 
modest redox responses while still inducing apoptosis, such modest changes may have 
rather significant implications for the risk of adverse outcomes of pregnancy, like preterm 
birth. However, it is worth noting that the biological significance of such low-level 
changes in ROS generation, GSSG, and antioxidant gene expression, though consistent, 
may be limited or even result in no functional change within the cell.  
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In summary, we have shown that exposure to the prototypical chemical oxidant 
TBHP stimulated caspase 3/7 activity, a hallmark of apoptosis. Apoptosis of trophoblast 
cells may increase risk for preterm deliveries by weakening the structural integrity of the 
extraplacental membrane tissue or attachment of the placenta to the uterine wall. We also 
observed modest changes in redox-related responses involving ROS, GSSG, ARE 
activity, and antioxidant gene expression. Additional studies are needed to determine 
whether low level changes in cellular redox conditions such as those observed in our 
study can, in fact, mediate end points of pathophysiologic significance such as gestational 





Figure 2.1. Effects of TBHP on HTR-8/SVneo cell caspase 3/7 activity and viability. 
A) Treatment effects of TBHP on caspase 3/7 activity. Cells were exposed to 0, 12.5, 25, 
or 50 µM TBHP for 4, 8, or 24 h. Caspase 3/7 activity was measured using a 
luminescence caspase assay. Camptothecin (in 0.1% DMSO vehicle) was included as a 
positive control for apoptosis. Data are presented as the mean ± SEM of 4 experiments. *, 
Significantly different compared to time-matched control (p<0.05). ∞, Significantly 
different compared with time-matched cells treated with 25 µM TBHP (p<0.05). #, 
Significantly different compared to time-matched camptothecin vehicle control (p<0.05). 
Camptothecin vehicle control (0.1% DMSO alone) had no significant effect on caspase 
activity (data are not shown). B) Deferoxamine (DFO) inhibits TBHP-stimulated caspase 
3/7 activity. HTR-8/SVneo cells were pretreated with 1mM deferoxamine (DFO) for 1 h, 
and then exposed to 50 µM TBHP for 8 or 24 h. Filled bars represent treatment with 
TBHP and unfilled bars represent cells not treated with TBHP. Data are presented as 
mean ± SEM of 4 experiments. *, Significantly different compared with the untreated 
controls (p<0.05). #, Significantly different compared with TBHP alone treatment 
(p<0.05). C) Effect of TBHP on cellular viability. Cells were exposed to 0, 12.5, 25, or 
50 µM TBHP for 4, 8, or 24 h. Cell viability was assessed by a luminescent ATP assay as 
described in the materials and methods. Camptothecin (in 0.1% DMSO vehicle) was 
included as a positive control. *, Significantly different compared to time-matched 
control (p<0.05). ∞, Significantly different compared with time-matched 25 µM TBHP-




Figure 2.2. Treatment effects of TBHP on reactive oxygen species (ROS) formation. 
Cells were treated with 0, 50, 100, or 200 µM TBHP for 2 h. Detection of ROS was 
performed using the redox sensitive probe DCF as described in the materials and 
methods. Data are represented as mean ± SEM fold change in DCF fluorescence relative 
to the control of 3 experiments. Average control values were 77.0 ± 2.8 relative 








Figure 2.3. Effect of TBHP on reduced and oxidized glutathione cellular 
concentrations and the gluathione redox potential (Eh). HTR-8/SVneo cells were 
treated with 50 µM TBHP for 0, 15, 30, 45, or 60 min. A) Concentrations of cellular 
reduced glutathione (GSH) relative to total protein content. B) Concentrations of cellular 
oxidized glutathione (GSSG) relative to total protein content. C) Intracellular glutathione 
redox potential (Eh). Data are represented as mean ± SEM of 3 experiments. *, 




Figure 2.4. Effect of TBHP on antioxidant response element (ARE) reporter activity. 
HTR-8/SVneo cells were treated with 50 µM TBHP for 0.5, 1, 2, 4, 6, or 8 h. 
Sulforaphane (10 µM) was included as a positive control. Reporter assays were 
performed as described in the materials and methods. Data are presented as mean ± SEM 
fold change over the control (dashed line) for each respective time point. To derive fold 
changes, Firefly luciferase relative light unit (RLU) values were first normalized to 
Renilla luciferase to compensate for cell number and transfection efficiency, then fold 
changes were calculated relative to control (cells that did not receive treatment) for each 
time point. For exposure durations of 0.5 and 1 h, n=1 experiment. For exposure times of 
2, 4, and 6 h, n=4 experiments. For the 8 h time point, n=3 experiments. Because of low 
experimental number, statistical analysis was performed only at 2, 4, 6, and 8 h. *, 
Significantly different compared to time-matched control (p<0.05).  
  












































Figure 2.5. Treatment effects of TBHP on TXNRD1 and GLRX2 mRNA expression. 
HTR-8/SVneo cells were treated with 0, 12.5, 25, or 50 µM TBHP for 4, 8, or 24 h. A) 
Cellular TXNRD1 mRNA expression. B) Cellular GLRX2 mRNA expression. Data are 
represented as mean ± SEM of 4 experiments. Fold changes were calculated using the 
ΔΔCt method (Yuan et al. 2006). The target gene from each sample was first normalized 
to the housekeeping gene B2M, and then fold changes were calculated relative to the 
normalized control. *, Significantly increased compared to time-matched controls 
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CHAPTER 3  
TERT-BUTYL HYDROPEROXIDE STIMULATES PGE2 RELEASE FROM A 
HUMAN PLACENTAL CELL LINE 
ABSTRACT 
Preterm birth is a significant public health problem. Although parturition is 
associated with biomarkers for damage due to exposure to reactive oxygen species (ROS) 
within gestational tissues, the impact of ROS on parturition-promoting pathways in 
gestational cells has received little attention within the literature. The present study 
examined the effect of oxidative insult on production of prostaglandins (PG), well-
established mediators involved in parturition promotion, using the human extravillous 
trophoblast cell line HTR-8/SVneo and the model ROS-producing chemical tert-butyl 
hydroperoxide (TBHP). After 4, 8 or 24 h exposures to 12.5, 25 or 50 µM TBHP, PGE2 
release, mRNA expression of prostaglandin-endoperoxide synthase 2 (PTGS2), 
hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD), prostaglandin E synthase 
(PTGES), and PTGS1 expression were assayed. Treatment with 50 µM TBHP at 4 and 24 
h, and 25 µM TBHP at 8 and 24 h, induced significant increases in PGE2 release into the 
culture medium (p<0.05). This was also accompanied by significant increases in PTGS2 
mRNA expression at 4, 8 and 24 h and a significant decrease in HPGD mRNA 
expression at 24 h. Cotreatment with the PTGS inhibitor indomethacin or the antioxidants 
butylated hydroxyanisole (BHA) and diphenyl phenylenediamine (DPPD) blocked the 
TBHP-stimulated PGE2 response. Treatment with TBHP increased phosphorylation of 
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p38 MAPK, indicative of activation, and pretreatment with the p38 MAPK inhibitor 
PD169316 blocked the TBHP-stimulated increases in PGE2 and PTGS2, suggesting 
dependence of the prostaglandin response on p38 MAPK activity. In summary, these 
results suggest that exposure to the ROS-producing chemical TBHP stimulates responses 
in human placental cells linked to parturition. Because ROS are a common effector in 
toxic responses, these findings suggest a potential mechanism by which environmental 
pollutant exposures increase risk for preterm birth. 
INTRODUCTION 
Preterm birth is defined as birth before 37 weeks of gestation (World Health 
Organization 2010). In the United States, it is the leading cause of infant mortality 
(Callaghan et al. 2006) and accounts for approximately 12% of births (Martin et al. 
2012). Furthermore, untimely birth also increases risk for multiple adverse outcomes 
including respiratory impairments (Baraldi and Filippone 2007) and neurodevelopmental 
deficits (Colvin et al. 2004). Although infection during pregnancy is acknowledged as a 
leading cause of preterm birth (Goldenberg and McClure 2010), the etiology is unknown 
in about half of all cases of preterm birth (Muglia and Katz 2010). Therefore, it has been 
recommended that additional research is needed to understand the causes of preterm birth 
(Behrman and Butler 2007). Suggesting that the environment may impact initiation of 
preterm birth, environmental chemical exposures, including lead (Dietrich 1991; Jelliffe-
Pawlowski et al. 2006; Torres-Sánchez et al. 1999), organochlorine pesticides (Pathak et 
al. 2009; Pathak et al. 2010), and phthalates (Meeker et al. 2009), have been associated 
with its increased risk.  
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A potential mechanism, common to many environmental chemicals, that may 
increase risk for preterm birth is through formation of reactive oxygen species (ROS). 
Within the cell, ROS can act as second messenger signaling molecules (Poole and Nelson 
2008). Oxidation of sensitive thiol residues on proteins can act as a switch, regulating 
protein activity, and resulting in modulation of signal transduction kinase and 
transcription factor activity (Poole and Nelson 2008). Reactive oxygen species increase 
production of prostaglandins and expression of prostaglandin-endoperoxide synthase 2 
(PTGS2), the inducible isoform of the PTGS enzymes, in a variety of non-gestational 
cells and tissues (Adderley and Fitzgerald 1999; Li et al. 2002; Nakamura and Sakamoto 
2001), by stimulating mitogen-activated protein kinases (MAPK) and transcription 
factors including nuclear factor-κB (Adderley and Fitzgerald 1999). Prostaglandins are 
lipid-signaling molecules that are increased during labor in all mammalian species 
(Young 2001) and stimulate myometrial contractions, cervical ripening, and membrane 
ruptures (Olson and Ammann 2007). They are, therefore, critical mediators to the 
progression of parturition. 
Markers for cellular damage due to ROS have been associated with adverse 
pregnancy outcomes, including preterm birth. Increased urinary excretion of 8-
hydroxydeoxyguanosine (8-OHdG), a marker for ROS-induced DNA damage, is 
associated with decreased gestation length and low birthweight (Stein et al. 2008). 
Another study finds similar associations between malondialdehyde and protein carbonyl 
levels in maternal blood and cord blood and preterm birth (Pathak et al. 2010). In 
addition, it has been speculated that iron-derived ROS due to bleeding during pregnancy 
may cause preterm birth (Sakata et al. 2008). 
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Although it has been suggested that preterm birth might be associated with 
conditions of oxidative stress (Pathak et al. 2010), the mechanistic links between ROS 
and parturition-promoting pathways within the gestational compartment has received 
relatively limited attention. The purpose of this study is to examine the effect of a 
prototypical pro-oxidant chemical, tert-butyl hydroperoxide (TBHP), on prostaglandin 
production from a human placental trophoblast-derived cell line, HTR-8/SVneo.  
MATERIALS AND METHODS 
Materials 
Tert-butyl hydroperoxide (TBHP; 70%), N,N'-diphenyl-p-phenylenediamine 
(DPPD), butylated hydroxyanisole (BHA), indomethacin, dimethyl sulfoxide (DMSO), 
Trizma, sodium chloride, Tween 20, Ponceau S solution, bovine serum albumin (BSA), 
sodium dodecyl sulfate (SDS), and 2-mercapthoethanol were from Sigma-Aldrich (St. 
Louis, MO). The inhibitor PD169316 was purchased from EMD Millipore (Billerica, 
MA). The inhibitors U0126 and SP600125 were from Enzo Life Sciences (Farmingdale, 
NY). Heat-inactivated fetal bovine serum (FBS), RPMI 1640 medium supplemented with 
L-glutamine and without phenol red, Opti-MEM I Reduced Serum Medium 
supplemented with L-glutamine and hydroxyethyl piperazineethanesulfonic acid 
(HEPES) and without phenol red, penicillin/streptomycin (10,000 units/mL and 10,000 
µg/mL, respectively), and Dulbecco’s phosphate-buffered saline (dPBS) were purchased 
from Gibco Life Technologies (Carlsbad, CA). We purchased prostaglandin enzyme 
immunoassay (EIA) kits from Cayman Chemical (Ann Arbor, MI). QIAshredder columns 
and RNeasy kits were from Qiagen (Germantown, MD). We used RT2 First Strand Kits, 
RT2 SYBR Green qPCR Mastermix, prostaglandin-endoperoxide synthase 1(PTGS 1), 
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PTGS2, prostaglandin E synthase (PTGES), hydroxyprostaglandin dehydrogenase 15-
(NAD) (HPGD), and β-2-microglobulin (B2M) RT2 qPCR Primer Assays from 
SABiosciences, Qiagen (Germantown, MD). IGEPAL CA-630 (NP-40 substitute) was 
purchased from United States Biological (Salem, MA). PhosStop protease inhibitor 
cocktail and cOmplete mini protease inhibitor cocktail tablets were from Roche 
(Indianapolis, IN). Reducing Laemmli SDS sample buffer was purchased from Boston 
BioProducts (Ashland, MA). Memcode reversible protein staining kit and bicinchoninic 
acid (BCA) assay kit were from Thermo Scientific (Waltham, MA). We purchased 
antibodies for phospho-p38 MAPK (Thr180/Tyr182), total p38 MAPK, and β-tubulin, as 
well as alkaline phosphatase-linked secondary antibody, from Cell Signaling Technology 
(Beverly, MA). Enhanced chemifluorecence (ECF) substrate and PVDF membrane 
Hybond-P were from GE Healthcare Life Sciences (Pittsburgh, PA).  
Cell culture and treatment 
The human trophoblast cell line HTR-8/SVneo was kindly provided by Dr. 
Charles H. Graham, Queen’s University, Kingston, Ontario, Canada. This immortalized 
cell line consists of first trimester extravillous trophoblast-derived cells transfected with 
the SV40 T antigen (Graham et al. 1993). HTR-8/SVneo cells are known to have similar 
phenotypes to their primary counterparts; they express HLA-G (Khan et al. 2011; Kilburn 
et al. 2000) antigens, produce human chorionic gonadotropin, urokinase-plasminogen 
activator (Graham et al. 1993), and matrix metalloproteinases (Jovanović and Vićovac 
2009; Jovanović et al. 2010), and cellular migration is controlled in response to similar 
stimulation (Jovanović and Vićovac 2009; Jovanović et al. 2010; Nicola et al. 2005; 
Paiva et al. 2009).  
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HTR-8/SVneo cells were maintained as previously described (Tetz et al. 2013). 
Briefly, HTR-8/SVneo cells between passages 73-87 were incubated in a humidified 
environment at 37°C with 5% CO2 in RPMI 1640 medium supplemented with 10% FBS, 
100 U/mL penicillin, and 100 µg/mL streptomycin. Cells were allowed to reach about 70-
80% confluence 24 h after subculture before starting an experiment. For time course 
experiments, 500,000 cell/well were seeded in 6-well plates. For antioxidant and MAPK 
inhibitor experiments, HTR-8/SVneo cells were seeded at a density of 100,000 cells/well 
in 24-well plates. Cells were seeded at a density of 1x106 in 60 mm dishes for western 
blotting experiments.  
Tert-butyl hydroperoxide was used in these experiments as a model ROS-
producing chemical because of its ability to cross the plasma membrane and generate 
ROS intracellularly (Ahmed-Choudhury et al. 1998). For time course experiments, 
culture medium was removed by aspiration and cells were treated with 12.5, 25, or 50 
µM TBHP, diluted directly into culture medium. For experiments involving inhibitors, 
vehicle controls (0.1-0.4% DMSO) and no treatment controls were run in parallel to 
treatment groups. Cells were pretreated with the MAPK inhibitors PD169316 (10 µM), 
U0126 (5 µM), and SP600125 (5 µM) for 1 h before removal and subsequent exposure to 
TBHP. Concentrations of MAPK inhibitors were chosen based on efficacy in previous 
studies (Shaul and Seger 2004; Renaud et al. 2009). In experiments with antioxidants or 
indomethacin, cells were cotreated with TBHP. In western blotting experiments, cells 
were exposed to reduced serum to reduce basal phosphorylation (Shaul and Seger 2004) 
in OptiMEM I supplemented with 1% FBS for 18 h before treatment.  
Enzyme immunoassays 
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Following conclusion of treatment, cell culture medium was collected, clarified 
by centrifugation, aliquoted, and stored at -80°C until analysis. In some experiments, 
experimental replicates were combined before analysis. Quantification of prostaglandin 
content was performed by enzyme immunoassay (EIA) according to manufacturer’s 
instructions. Values below the assay limit of detection, the lowest non-zero value on the 
back-calculated standard curve, were assigned a value of one-half the limit of detection. 
All samples were analyzed in triplicate.  
Quantitative real-time PCR 
Following removal of culture medium, cells were homogenized using Qiashredder 
columns, replicate homogenates were pooled, and RNA was extracted using RNeasy 
columns according to manufacturer’s instructions. One microgram total RNA was reverse 
transcribed using RT2 first strand kits according to manufacturer’s instructions. 
Quantitative RT-PCR reactions were performed on a Bio-Rad CFX Connect Real-Time 
System or Bio-Rad CFX96 Real-Time System C1000 thermal cyclers according to RT2 
SYBR Green Mastermix directions. The housekeeping gene B2M was run in parallel 
reactions as a means of normalization. Fold changes in target mRNA expression was 
quantified using the ΔΔCt method (Yuan et al. 2006) on CFX manager software version 
3.0 (Bio-Rad, Hercules, CA). All samples were assayed in triplicate.  
Western blot 
After treatments were removed, cells were washed twice with ice-cold dPBS, 
incubated with lysis buffer (0.5% IGEPAL, 250 mM NaCl, 50 mM tris-HCl, with 2X 
protease and phosphatase inhibitor tablets), cells were scraped, and cellular protein was 
collected. Lysates were clarified, aliquoted, and stored at -80°C until analysis. Total 
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protein was quantified by BCA assay. Protein was boiled in sample buffer, 25 µg protein 
was subjected to SDS-polyacrylamide gel electrophoresis, and electrotransfer to PVDF 
membrane. Transfer efficiency was confirmed by reversible membrane staining 
(Memcode or Ponceau). Membranes were blocked at room temperature for 1 h with 5% 
milk in tris-buffered saline supplemented with 0.1% tween (TBST; 20 mM Tris-HCl, 137 
mM NaCl, pH 7.6). Membranes were probed with primary antibodies overnight at 4°C 
with agitation in 5% BSA TBST. Following wash, membranes were incubated with 
alkaline phosphatase-conjugated secondary antibodies for 1 h at RT in 5% milk TBST. 
All antibodies were diluted at 1:2000. Bands were imaged after developing the blot with 
ECF for 5 min and imaged on a Fujifilm Fluorescent Image Analyzer FLA-5000. Blots 
were stripped before reprobing for total p38 MAPK using stripping buffer (100 mM 2-
mercaptoethanol, 2% (w/v) SDS, 62.4 mM Tris-HCl, pH 6.7) with constant agitation at 
50°C for 30 min. Images shown are representative of 3 individual experiments. 
Densitometry was used to semi-quantitate data with ImageJ software (National Institutes 
of Health) as described previously (Miller 2010). 
Statistics 
Data were analyzed using SigmaPlot version 11.0 (Systat Software, Chicago, IL) 
by repeated-measures one-way or two-way analysis of variance (ANOVA) with Tukey 
post-hoc analysis, where appropriate. In cases where data were non-normal or had 
unequal variance, data were log-transformed before analysis. For qRT-PCR analysis, ΔCt 
values were the statistics utilized for analysis (Yuan et al. 2006).  
 60 
RESULTS 
Effect of TBHP stimulates on HTR-8/SVneo PGE2 release and PTGS2 mRNA 
expression 
HTR-8/SVneo cells were treated with 12.5, 25, or 50 µM TBHP for 4, 8, or 24 h. 
Treatment with 12.5 µM TBHP failed to stimulate significant increases in PGE2 at any of 
the time points assayed (Figure 3.1A). Treatment with 50 µM TBHP stimulated 
significant increases of 7.2, 2.8, and 4.8 fold at 4, 8, and 24 h, respectively (p<0.05). 
Treatment with 25 µM TBHP significantly increased PGE2 release by 3.1 fold at 8 h and 
2.7 fold at 24 h (p<0.05). With 24 h exposure, the stimulated PGE2 increase with 50 µM 
TBHP was significantly greater than the increase due to 25 µM (p=0.010).  
Because prostaglandin production is rate-limited by PTGS2 activity, we assessed 
changes in PTGS2 mRNA expression following treatment with TBHP. Treatment with 
12.5 and 25 µM TBHP failed to stimulate significant increases in PTGS2 mRNA (Figure 
3.1B). However, treatment with 50 µM TBHP stimulated significant increases of 10.6, 
7.6 and 3.2 fold increases compared with time-matched controls at 4, 8, and 24 h 
(p<0.05).  
Next, we examined the effect of TBHP on mRNA expression of other enzymes in 
the PGE2 metabolic pathway. Treatment with 50 µM TBHP stimulated a significant 
decrease in the mRNA expression in the prostaglandin catabolic enzyme HPGD with 24 
h treatment (Figure 3.2; p=0.02). We also assessed TBHP treatment effects on mRNA 
expression of PTGS1 and PTGES, but observed no significant changes (see Appendix 
A.1). 
Effect of PTGS inhibitor on TBHP-stimulated PGE2 release  
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We assessed dependence of TBHP-stimulated PGE2 release on increased PTGS2 
activity using indomethacin, a PTGS inhibitor (Vane et al. 1998). Indomethacin 
significantly blocked TBHP-stimulated PGE2 release at 4 and 24 h (p<0.05), returning 
PGE2 to levels near those observed with vehicle controls (Figure 3.3A and B; p<0.05). A 
24 h coincubation of TBHP with the inhibitor vehicle (1% DMSO) decreased stimulated 
PGE2 compared to controls incubated with TBHP alone (p<0.05). This is not altogether 
surprising considering that DMSO can act as an antioxidant (Repine et al. 1979; 
Vlahopoulos et al. 1999). We did not observe any significant changes in PTGS2 mRNA 
expression due to cotreatment with indomethacin (data not shown), consistent with a 
previous report that indomethacin does not exert its effect at the transcriptional level 
(Vane et al. 1998). 
Antioxidant effects on TBHP-stimulated PGE2 release 
We assessed dependence of PGE2 release on oxidative mediators by cotreating 
cells with TBHP and the antioxidants BHA or DPPD. Cotreatment with BHA or DPPD 
completely prevented TBHP-stimulated release of PGE2 compared to the TBHP + vehicle 
control (Figure 3.4A and B; p<0.05).  
Effects of MAPK inhibitors on TBHP-stimulated PGE2 release and PTGS2 
expression 
The MAPKs are a family of redox-sensitive signal transduction enzymes 
(McCubrey et al. 2006) whose activity can mediate prostaglandin production (Smith et al. 
2000). HTR-8/SVneo cells were pretreated with MAPK inhibitors and then treated with 
50 µM TBHP for 4 or 24 h. Pretreatment with the p38 MAPK inhibitor PD169316 
significantly decreased TBHP-stimulated PGE2 at 4 and 24 h (Figure 3.5A and B; 
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p<0.05). Both the ERK 1/2 inhibitor U0126 and the JNK inhibitor SP600125 failed to 
significantly decrease TBHP stimulated PGE2.  
We also examined the effects of MAPK inhibitors on HTR-8/SVneo PTGS2 
mRNA expression. Pretreatment with 10 µM PD169316 significantly blocked TBHP-
induced PTGS2 mRNA expression compared with the TBHP + vehicle control (Figure 
3.5C; p<0.05). Similar to observations with PGE2 release, pretreatment with U0126 and 
SP600125 failed to significantly decrease PTGS2 mRNA. We also observed that 
pretreatment with PD169316 and SP600125 significantly decreased basal mRNA 
expression by 64 and 38% (p<0.05).  
p38 MAPK phosphorylation 
To document TBHP-stimulated activation of p38 MAPK, phosphorylation of p38 
was assessed by western blot following treatment of HTR-8/SVneo cells with 50 µM 
TBHP. Treatment at all exposure durations, except 1 h, resulted in significant increases in 
phosphorylation of p38 (Figure 3.6A and B; p<0.05). There were no significant changes 
in total p38 (Figure 3.6A, data not shown).  
DISCUSSION 
The role of ROS in stimulation of parturition-associated pathways in cells of 
human gestation has been scarcely studied. The purpose of this study is to examine the 
effect of the prototypical pro-oxidant chemical TBHP on parturition-promoting pathways 
involving prostaglandin synthesis in a human gestational cell model.  
Because of its importance in the progression of labor (Olson and Ammann 2007), 
we studied PGE2 release following exposure to TBHP. In accordance with previous 
studies with HTR-8/SVneo cells, basal levels of PGE2 were very low or undetectable 
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(Horita et al. 2007; Nicola et al. 2005). Treatment with TBHP stimulated increases within 
4 h of exposure and these increases were sustained through 8 and 24 h. Consistent with 
our findings, a different ROS-producing oxidant chemical, H2O2, stimulates PGE2 
increases from pig endothelium (Thengchaisri and Kuo 2003), mouse kidney cells 
(Soodvilai et al. 2007), and mouse embryonic stem cells (Lee et al. 2009). In contrast, 
exposure to H2O2 resulted in decreased prostanoid production, including PGE2, from 
human vessel segments (Yamaja Setty et al. 1984). However, within the gestational 
compartment, less is known about the impact of oxidative insult on prostaglandin 
synthesis. PGE2 is stimulated by H2O2 in human amnion epithelium, amnion fibroblast 
(Kumar et al. 2004b), and amnion-derived WISH cells (Kumar et al. 2004a). In rat corpus 
luteum, lipid hydroperoxides also induce PGE2 release (Kodaman et al. 1994). Results 
presented here are consistent with the limited studies of cells derived from gestational 
tissues, and suggest that PGE2 may be produced as a result of exposure to ROS-
producing chemicals.  
A key step in the biosynthesis of prostaglandins is the conversion of arachidonic 
acid to PGH2, catalyzed by cyclooxygenases PTGS1 and PTGS2 (Chandrasekharan and 
Simmons 2004; Smith et al. 2000; Vane et al. 1998). PGH2 is then isomerized to PGE2 by 
prostaglandin E synthases (Park et al. 2006). We found increased mRNA expression of 
PTGS2 following treatment with TBHP. Consistent with our findings, expression of 
PTGS2, the inducible cyclooxygenase isoform (Dubois et al. 1998), is increased under 
with ROS in rat cardiomyocytes (Adderley and Fitzgerald 1999) and bovine luteal cells 
(Nakamura and Sakamoto 2001). Furthermore, observed increases in PTGS2 mRNA 
following TBHP were similar in magnitude to those found during labor: PTGS2 is 
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increased 50% in myometrium (Choi et al. 2007), 2 fold in placenta (Cindrova-Davies et 
al. 2007b), and over 10 fold in gestational membranes (Mijovic et al. 1998). 
Indomethacin, a non-selective inhibitor (Johnson et al. 1995) of PTGS activity (Vane 
1998), significantly decreased TBHP-stimulated PGE2 release, supporting dependence of 
PGE2 release on PTGS activity. We found no significant changes in mRNA expression of 
PTGES (also known as mPGES-1; Appendix A, Figure A.1B), an inducible, predominant 
prostaglandin E synthase isoform (Park et al. 2006). The latter finding fails to support a 
role for increased PTGES enzymes in TBHP-stimulated PGE2, suggesting that the 
increase is regulated upstream of PTGES. Because there is an associated induction of 
PTGS2 but not PTGS1 mRNA (Appendix A, Figure A.1A), we posit that TBHP-
stimulated PGE2 release is due, at least in part, to PTGS2 enzymatic activity. Indeed, in 
mouse embryonic stem cells, H2O2-stimulated PGE2 is mediated by PTGS2 activity (Lee 
et al. 2009). 
We found a significant decrease in mRNA expression of the prostaglandin 
catabolic enzyme HPGD. In addition to increased PTGS activity, diminished PGE2 
catabolic activity (Tai et al. 2006) could contribute to the increased PGE2 concentrations 
observed following treatment with TBHP. During pregnancy, HPGD expression in the 
chorion of the extraplacental membranes remains elevated until parturition (Challis et al. 
2002; Challis 2000), then decreases during parturition (Germain et al. 1994; Johnson et 
al. 2004; Sangha et al. 1994). Thus, decreases in HPGD protein expression in the 
extraplacental membranes may contribute to increased prostaglandin concentrations 
observed during labor (Challis 1999). Results from the present study are the first to 
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suggest that ROS may be involved in the regulated decrease in expression of HPGD 
observed during labor. 
TBHP is a model oxidant chemical popular for experiments with a variety of cells 
and tissues. TBHP produces oxygen-containing peroxyl and alkoxyl radicals in a reaction 
catalyzed by iron (Van der Zee et al. 1989). It stimulates responses sensitive to alterations 
in the cellular redox state, including depletion of reduced glutathione (Buc-Calderon et al. 
1991; Eklow et al. 1984; Lam et al. 2011; Martı́n et al. 2001), lipid peroxidation (Buc-
Calderon et al. 1991; Eaddy et al. 2012; Haidara et al. 2002; Kanupriya et al. 2007; 
Martı́n et al. 2001; Yajima et al. 1995), and apoptosis (Azizi et al. 2011; Haidara et al. 
2002; Kalia and Bansal 2008; Kanupriya et al. 2007). DPPD and BHA, which inhibited 
TBHP-stimulated PGE2 in the present study, are lipophilic, inhibit lipid peroxidation 
(Clark et al. 1985; Sogabe et al. 1996; Verhagen et al. 1991), and prevent oxidative 
membrane damage (Catalá 2009) in some cells. Because TBHP stimulated both PGE2 
release and PTGS2 mRNA expression, one mechanism by which BHA and DPPD may 
be blocking PGE2 production is by directly scavenging TBHP-derived ROS that drive 
PTGS2 expression. Along with PTGS activity, prostaglandin production is also limited 
by release of arachidonic acid from the cell membrane (Balsinde et al. 1999). Thus, 
another point of possible regulation for PGE2 production is via lipid peroxidation 
stimulated release of arachidonic acid. Indeed, lipid peroxidation is known to free 
arachidonate from cell membranes by stimulating phospholipase A2 (PLA2) activity in 
murine fibroblasts (van Rossum et al. 2004), macrophages (Martinez and Moreno 1996), 
and mesangial cells (Han et al. 2003) treated with H2O2 or superoxide. One study in 
human lung fibroblasts suggests that TBHP-stimulated prostaglandin release involves 
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regulation at two points in the prostaglandin synthetic pathway: release of arachidonic 
acid from the cell membrane and conversion of arachidonic acid to final prostaglandin 
products (Taylor et al. 1983). More studies are needed to determine whether TBHP 
stimulates PGE2 from HTR-8/SVneo cells in a similar two-step manner. An additional 
point of regulation at the cell membrane level may explain why we observed significant 
increases in PGE2 production with 25 µM TBHP, yet PTGS2 mRNA expression was not 
significantly increased with the same exposure.  
MAPKs are speculated to participate in pathways associated with parturition. 
Increased p38 MAPK phosphorylation is observed in labored cervical stroma (Wang and 
Stjernholm 2007), amnion, chorion trophoblasts (Lappas et al. 2011), decidual stroma, 
and myometrium (Takanami-Ohnishi et al. 2001). Here we found that TBHP-stimulated 
PGE2 release and PTGS2 mRNA expression were inhibited by PD169316, a 
pharmacologic inhibitor of p38 MAPK. Adding further weight to the potential 
involvement of p38 MAPK in TBHP-stimulated prostaglandin synthesis, TBHP 
stimulated phosphorylation of p38 MAPK, indicating activation of p38 MAPK (Roux and 
Blenis 2004). Consistent with this study, placental explants exposed to hypoxia 
reperfusion injury have increased p38 MAPK phosphorylation and PTGS2 protein 
expression, which are inhibited by PD169316 (Cindrova-Davies et al. 2007a). Taken 
together, these findings suggest that p38 MAPK may be a key parturition signaling 
protein whose activity can be stimulated by ROS-producing chemicals. However, future 
studies are needed to examine the mechanistic signaling targets in the pathway linking 
TBHP-stimulated lipid peroxidation, ROS, and p38 MAPK activity. One potential 
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molecular target includes the MAPK regulatory protein phosphatases whose activity is 
inhibited upon cysteine oxidation within their catalytic domains (Salmeen 2005).  
We recognize that there are limitations to this study. First, the levels of PGE2 
detected in this study are rather low, perhaps because of the low prostaglandin synthetic 
potential of HTR-8/SVneo cells (Horita et al. 2007; Nicola et al. 2005). In addition, 
because the HTR-8/SVneo cell line used in this study is an immortalized cell line derived 
from first trimester extravillous trophoblasts, targets identified in these experiments 
should be validated in late gestation primary cells and tissues that may be more relevant 
to premature birth. Moreover, recent publications suggest the epigenetic (Novakovic et al. 
2011) and transcriptomic (Bilban et al. 2010) profiles of HTR-8/SVneo cells differ from 
primary extravillous trophoblasts. Nevertheless, HTR-8/SVneo cells have proven to be a 
useful cell culture model for the study of trophoblast physiology (Hannan et al. 2010). 
Furthermore, HTR-8/SVneo cells are phenotypically similar to primary cells. 
Specifically, primary extravillous trophoblast responses to interleukin (IL)-6 (Jovanović 
and Vićovac 2009), IL-8 (Jovanović et al. 2010), and PGE2 (Nicola et al. 2005) are 
similar to that of HTR-8/SVneo cells. 
Moreover, these results may have implications for adverse pregnancy outcomes 
due to early events of pregnancy. In one study with the HTR-8/SVneo cells, PGE2 
inhibited trophoblast invasion and migration (Biondi et al. 2006), whereas others have 
shown stimulatory effects (Horita et al. 2007; Nicola et al. 2005; Nicola et al. 2008a; 
Nicola et al. 2008b). Dysregulation of extravillous trophoblast migration and, as a 
consequence, incomplete spiral artery transformation, have been implicated in the 
pathogenesis of preeclampsia (Merviel et al. 2004; Wang et al. 2009).  
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In sum, we found that exposure of a human trophoblast-derived cell line to the 
ROS-producing chemical TBHP induced synthesis of prostaglandins, mediators of 
particular relevance to the initiation of parturition. As such, stimulation of prostaglandin 
production may then increase risk for preterm birth by initiating myometrial contractions. 
Environmental chemical exposure has been linked to preterm birth in epidemiology 
studies (Dietrich 1991; Jelliffe-Pawlowski et al. 2006; Meeker et al. 2009; Pathak et al. 
2009; Pathak et al. 2010; Torres-Sánchez et al. 1999). Such chemicals, including 
phthalates (Ferguson et al. 2011; Kasahara et al. 2002; Seo et al. 2004; Tetz et al. 2013), 
lead (Ercal et al. 2001; Jomova and Valko 2011; Liu et al. 2010), and organochlorine 
pesticides (Ahmed et al. 2008; Banerjee et al. 2001; Pathak et al. 2010; Siddharth et al. 
2012), have been shown to stimulate production of ROS. Therefore, the present study 
identifies a potential mechanistic explanation for some reported associations between 




Figure 3.1. Treatment effects of TBHP on PGE2 release and PTGS2 mRNA 
expression. HTR-8/SVneo cells were treated with 0, 12.5, 25, or 50 µM TBHP for 4, 8, 
or 24 h. A) PGE2 concentrations in culture medium. B) Cellular PTGS2 mRNA 
expression. Data are represented as mean ± SEM of 3-4 experiments. Fold changes in 
PTGS2 mRNA expression were calculated using the ΔΔCt method (Yuan et al. 2006). To 
calculate fold changes in mRNA expression, the Ct values for each sample were 
normalized to its own housekeeping gene control, and then normalized its respective 
time-matched control. *, Significantly different compared to time-matched controls 





Figure 3.2. Effect of TBHP on prostaglandin metabolic enzyme mRNA expression. 
Changes in HPGD were measured in HTR-8/SVneo cells following treatment with 12.5, 
25, or 50 µM TBHP for 4, 8, or 24 h. Fold changes in HPGD mRNA expression were 
calculated using the ΔΔCt method (Yuan et al. 2006). Values represent mean fold 
changes ± SEM for 3 experiments. *, Significantly different p<0.05 compared with time-




Figure 3.3. Effect of indomethacin (Indo) on TBHP stimulated PGE2 release. HTR-
8/SVneo cells were cotreated with 50 µM TBHP (filled bars) or without TBHP (open 
bars), and vehicle (0.1% DMSO), or the PTGS inhibitor indomethacin (10 µM) for A) 4 h 
or B) 24 h. Bars represent mean ± SEM PGE2 concentration in culture medium for 3 
experiments. #, Signficantly different compared to vehicle + TBHP control (p<0.05).   
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Figure 3.4. Effect of antioxidants on TBHP-stimulated PGE2. HTR-8/SVneo cells 
were cotreated with 50 µM TBHP (gray bars), vehicle (0.1% DMSO), 1 µM butylated 
hydroxyanisole (BHA), or 25 µM diphenyl phenylenediamine (DPPD). Data represent 
mean ± SEM PGE2 concentration in culture medium for 3 experiments. *, Significantly 
different compared with cotreatment matched control (p<0.05). #, Significantly different 







Figure 3.5. Effect of MAPK inhibitors on TBHP-stimulated PGE2 release and 
PTGS2 mRNA expression. HTR-8/SVneo cells were pretreated with vehicle (0.4% 
DMSO), 10 µM PD169316, 5 µM U0126, or 5 µM SP600125 for 1 h. Pretreatments were 
removed and cells were then treated with 50 µM TBHP (filled bars) or received no 
further treatment for 4 or 24 h. PGE2 concentrations in culture medium at A) 4 h and B) 
24 h. C) Fold changes in PTGS2 mRNA after 4 h treatment with TBHP. Values represent 
mean ± SEM for 3 experiments. *, Significantly different compared to pretreatment 
matched control (p<0.05). #, Significantly different compared to vehicle + TBHP control 




Figure 3.6. Effect of TBHP on p38 MAPK phosphorylation. Phosphorylation of p38 
MAPK was assessed by western blot following treatment of HTR-8/SVneo cells with 50 
µM TBHP for 1, 1.5, 2, 2.5, 3, 3.5, or 4 h. A) Representative image of western blotting 
for phospho-p38 MAPK, total p38 MAPK, and β-tubulin loading control. B) Fold 
changes in p38 MAPK phosphorylation relative to 0 h time point (i.e., the untreated 
control). Densitometry data for p38 MAPK phosphorylation were normalized to the β-
tubulin loading control. Data represent mean ± SEM for 3 experiments. *, Significantly 
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CHAPTER 4  
TERT-BUTYL HYDROPEROXIDE STIMULATES RELEASE OF THE 
CYTOKINE INTERLEUKIN-6 FROM THE HUMAN PLACENTAL CELL LINE 
HTR-8/SVNEO 
ABSTRACT 
As a leading cause of infant morbidity and mortality, preterm birth is a problem 
that warrants further study. Damage due to reactive oxygen species (ROS) has also been 
associated with preterm birth. While the link between inflammatory pathways and 
initiation of parturition is well described, the effect of ROS on stimulated cytokine 
responses in human gestational tissues is unclear. As such, this study examines the effect 
of TBHP, a prototypical pro-oxidant chemical, on the cytokine interleukin-6 (IL-6) and 
nuclear factor-κB (NF-κB) in the human placental trophoblast-derived cell line HTR-
8/SVneo. Treatment with 50 µM TBHP at 24 h induced significant increases in IL-6 
release and NF-κB reporter activity (p<0.05). Stimulated IL-6 was blocked by the 
antioxidants butylated hydroxyanisole (BHA), diphenyl phenylenediamine (DPPD), and 
deferoxamine. (p<0.05). We also assessed dependence of responses on the redox 
sensitive mitogen activated protein kinases (MAPKs). Inhibition of p38 MAPK ablated 
the TBHP-stimulated the IL-6, but not NF-κB, response. Results from this study suggest 




Preterm birth is a significant public health problem associated with increased risk 
for mortality (Callaghan et al. 2006) and persistent morbidity (Saigal and Doyle). 
Inflammatory pathway activation is a key feature of both term and preterm labor 
(Christiaens et al. 2008). Cytokines are secreted messenger proteins that mediate 
inflammatory events and stimulate downstream pathways that drive labor (Christiaens et 
al. 2008). For instance, interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α are 
cytokines that induce uterotonic prostaglandin production from gestational tissues, 
including the placenta (Pomini et al. 1999) and extraplacental membranes (Kent et al. 
1993a; Kent et al. 1993b). Cytokines also stimulate myometrial contractions via 
induction of prostaglandins (Sadowsky et al. 2000) and early labor in vivo (Romero et al. 
1991; Sadowsky et al. 2006). Consequently, the identification of cellular mechanisms that 
lead to production of cytokines within the gestational compartment is critical to our 
understanding of the pathogenesis of preterm birth. 
Although the link between stimulation of inflammation and bacterial infection 
within the gestational compartment is well defined (Romero et al. 2007), preterm birth 
also occurs in the absence of detectable infection (Muglia and Katz 2010). Inflammation 
at the maternal-fetal interface may, therefore, have alternative etiologies, such as through 
reactive oxygen species (ROS)-initiated signaling (Pathak et al. 2010). Indeed, markers 
for oxidative DNA, lipid and protein damage, lipid peroxidation have been associated 
with shortened gestation length (Stein et al. 2008) and preterm birth (Pathak et al. 2010).  
Reactive oxygen species can act as signal transduction second messengers 
(Nathan 2003; Paulsen and Carroll 2009; Reth 2002). Reactive oxygen species mediate 
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inflammation and the production of proinflammatory cytokines in a variety of disease 
phenotypes including, diabetes, neurodenerative disease, and chronic obstructive 
pulmonary disease, among others (Chiurchiù and Maccarrone 2011; Hald and Lotharius 
2005; Rahman and Adcock 2006). However, there are limited studies to suggest such 
pathways exist in human gestational cells (Buhimschi et al. 2003; Cindrova-Davies et al. 
2007; Lappas et al. 2003). This study examines the effect of the chemical oxidant tert-
butyl hydroperoxide (TBHP) on release of the parturition-associated cytokine IL-6 in a 
human placental trophoblast cell line, HTR-8/SVneo. Specifically, we utilized TBHP to 
demonstrate ROS-mediated IL-6 release and the role of immunomodulatory signal 
transducers, MAPK and NF-κB, on this response.  
MATERIALS AND METHODS 
Materials 
RPMI 1640 medium supplemented with L-glutamine and without phenol red, 
heat-inactivated fetal bovine serum (FBS), penicillin/streptomycin (10,000 units/mL and 
10,000 µg/mL, respectively), 0.25% trypsin-EDTA, 10 mM non-essential amino acids in 
minimal essential medium, and Opti-MEM I Reduced Serum Medium supplemented with 
L-glutamine and hydroxyethyl piperazineethanesulfonic acid (HEPES) and without 
phenol red were purchased from Gibco Life Technologies (Carlsbad, CA). Deferoxamine 
mesylate salt (DFO), 70% tert-butyl hydroperoxide (TBHP), dimethyl sulfoxide 
(DMSO), N,N'-diphenyl-p-phenylenediamine (DPPD), butylated hydroxyanisole (BHA), 
and indomethacin were purchased from Sigma-Aldrich (St. Louis, MO). PD169316 was 
purchased from EMD Millipore (Billerica, MA), and U0126 and SP600125 were 
purchased from Enzo Life Sciences (Farmingdale, NY). Lipopolysaccharide (LPS, 
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Salmonella typhimurium) was from List Biological Laboratories (Campbell, CA). Dual 
Luciferase luminescent assays were purchased from Promega (Madison, WI). NF-κB 
Cignal reporter assay kit and Attractene transfection reagent were purchased from Qiagen 
(Germantown, MD).   
Cell culture and treatments 
HTR-8/SVneo cells were kindly provided as a gift from Dr. Charles H. Graham 
(Queen’s University, Kingston, Ontario, Canada). The HTR-8/SVneo cells are human 
extravillous trophoblast cells derived from first trimester placentae and immortalized 
using the SV40 T antigen (Graham et al. 1993). These cells share many phenotypic 
similarities to primary extravillous trophoblasts (Jovanović and Vićovac 2009; Jovanović 
et al. 2010; Nicola et al. 2005). HTR-8/SVneo cells between passages 73-87 were 
maintained at 37°C in a humidified incubator with 5% CO2 in RPMI 1640 medium 
supplemented with 10% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin for 2-3 
days until disaggregated by trypsinization. For time-course IL-6 experiments, 500,000 
cells/well were seeded in 6-well plates. For antioxidant and MAPK inhibitor experiments, 
HTR-8/SVneo cells were seeded at a density of 100,000 cells/well in 24-well plates. For 
transfection assays, cells were seeded at density of 20,000 cells/well in 96-well white, 
clear-bottom plates. HTR-8/SVneo cultures were allowed to reach about 70-80% 
confluence 24 h after subculture before initiating an experiment. All treatments were 
performed in triplicate. 
Cells were treated with tert-butyl hydroperoxide as a model ROS-producing 
chemical that readily passes across the plasma membrane to enter cells (Ahmed-
Choudhury et al. 1998). Intracellularly, TBHP produces tert-butyl alkoxyl and tert-butyl 
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peroxyl radicals in a series of iron-catalyzed reactions similar to the Fenton and Haber-
Weiss reactions (Huang et al. 2005). For time-course experiments, culture medium was 
aspirated and cells were treated with 12.5, 25, or 50 µM TBHP (dissolved directly into 
culture medium), or medium alone. For experiments with treatments that preceded TBHP 
exposure, medium was aspirated and cells were pretreated with 1 mM DFO (dissolved 
directly into medium), 0.1% DMSO (solvent control for MAPK inhibitors), 10 µM 
PD169316, 5 µM U0126, 5 µM SP600125, or medium alone (untreated control). One 
hour later, medium was aspirated, and cells were treated with 50 µM TBHP or medium 
alone for 24 h. For experiments that included indomethacin or antioxidants, cells were 
coexposed to 50 µM TBHP and 0.1% DMSO (solvent control), 10 µM indomethacin, 1 
µM BHA, or 25 µM DPPD for 24 h. Additional cultures of HTR-8/SVneo cells were 
exposed to 100 ng/mL LPS, included as a positive control for cytokine release (Svinarich 
et al. 1996) and NF-κB reporter activity (Dai et al. 2011).  
Analysis of IL-6 release 
TBHP-stimulated IL-6 release into culture medium was determined by ELISA. 
Culture medium was collected, clarified by centrifugation, aliquoted, and stored at -80°C 
until analysis. Samples were analyzed in duplicate for IL-6 using a human specific 
ELISA kit (R&D systems Duoset) by the University of Michigan Cancer Center 
Immunology Core, according to manufacturer’s instructions. Values below the assay 
limit of detection, the lowest non-zero value on the back-calculated standard curve, were 
assigned a value of one-half the limit of detection.  
Transfections and reporter assays 
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NF-κB activity was assessed using a commercially available reporter construct 
(SABiosciences, Qiagen). The reporter consists of a mixture of inducible firefly 
luciferase gene downstream of tandem NF-κB consensus binding site repeats and 
constitutive Renilla luciferase gene controlled by CMV promoter. Suspensions of HTR-
8/SVneo cells were seeded into 96-well plates containing transfection reagent (Qiagen) 
complexed with negative control, positive control, or NF-κB reporter constructs. Cells 
were allowed to adhere and transfect for 6 h followed by an 18 h recovery period at 37°C 
in a humidified incubator with 5% CO2. Cells were then treated in triplicate with TBHP 
for 24 h, medium was aspirated, and cells were lysed in Passive Lysis Buffer (Promega). 
Dual luciferase assays (Promega) were performed according to manufacturer’s 
instructions.  NF-κB firefly luciferase activity was normalized to luciferase activity of 
Renilla, included as an internal control for cell number and transfection efficiency.  Data 
are presented as the fold change in luciferase activity normalized to the control. Cells 
were maintained in OptiMEM I + 1% NEAA + 3% FBS throughout the duration of 
transfection experiments.   
Statistics 
Data were compared by repeated-measures one-way or two-way analysis of 
variance (ANOVA) with Tukey post-tests using SigmaPlot version 11.0 (Systat Sofware).  
RESULTS 
Effect of TBHP on IL-6 release from HTR-8/SVneo cells 
 Exposure to 50 µM TBHP for 24 h stimulated a significant 2.3 fold increase in 
IL-6 release from HTR-8/SVneo cells compared to untreated control (Figure 4.1; 
p=0.005). Exposure to TBHP at earlier time points (4 and 8 h) and with lower 
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concentrations (12.5 and 25 µM TBHP) failed to significantly increase IL-6 release. LPS 
(100 ng/mL), included as a positive control, stimulated significant increases (p<0.001) in 
IL-6 release of about 3 fold compared to the untreated control at each of the time points 
assessed. Based on these results, we used treatment with 50 µM TBHP for 24 h in 
subsequent experiments to explore the mechanism of ROS-stimulated IL-6 release. 
Antioxidant exposure effects on TBHP-stimulated IL-6 release 
 Because TBHP stimulates formation of free radicals via an iron-catalyzed reaction 
(Davies 1989; Van der Zee et al. 1989), we used the iron-chelating agent DFO to test the 
hypothesis that TBHP stimulates IL-6 release by an iron-dependent mechanism. As 
observed in Figure 4.2A, treatment with 50 µM TBHP for 24 h significantly increased IL-
6 release compared with the non-pretreated group (p<0.001). Notably, pretreatment with 
1 mM DFO for 1 h prevented TBHP-stimulated IL-6 release (p<0.001). Exposure to 1 
mM DFO alone had no significant effect on IL-6 release compared with untreated 
control.  
 Because BHA and DPPD inhibited the effects of TBHP in our previous 
experiments (see Chapter 3), we used the antioxidants BHA and DPPD to assess 
dependency of IL-6 release on TBHP-induced ROS. HTR-8/SVneo cells were co-
exposed to 50 µM TBHP, 1 µM BHA, 25 µM DPPD, antioxidant vehicle (0.1% DMSO; 
vehicle controls), or medium alone (untreated controls). Cotreatment with BHA 
significantly suppressed TBHP-stimulated IL-6 release compared with the vehicle control 
(52.3 ± 3.7 pg/ml vs. 81.0 ± 10.6 pg/ml, respectively; Figure 4.2B; p<0.001). Similarly, 
cotreatment with DPPD quelled stimulated IL-6 release (51.6 ± 4.1 pg/ml) compared with 
the TBHP + vehicle control (p<0.001). However, the BHA and DPPD treatments were 
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not able to completely block IL-6 release, and TBHP still stimulated significant increases 
of 2.3 and 2.2 fold, respectively, compared with vehicle controls (p<0.001).  Treatment 
with antioxidants without TBHP had no significant effect on IL-6 release.  
Effect of indomethacin on TBHP-stimulated IL-6 release 
 Previously, we found that TBHP increased PGE2 release within 4 h exposure (see 
Chapter 3). Because PGE2 release preceded IL-6 release temporally, we hypothesized 
dependency of IL-6 release on PGE2. We pretreated with PTGS inhibitor indomethacin to 
test this hypothesis. Indomethacin failed to block TBHP-stimulated IL-6 release in HTR-
8/SVneo cells, with similar levels of IL-6 observed in cultures co-exposed to 50 µM 
TBHP and 10 µM indomethacin compared with TBHP + vehicle (0.1% DMSO) or TBHP 
alone (Figure 4.3; p<0.05).  
Effect of MAPK inhibitors on TBHP-stimulated IL-6 release 
We used inhibitors of specific MAPK pathways to examine the dependency of 
TBHP-stimulated IL-6 release on MAPK activity. Pretreatment for 1 h with 10 µM 
PD169316, a p38 MAPK inhibitor, blocked TBHP-stimulated IL-6 release (Figure 4.4; 
compare vehicle + PD169316 + TBHP group with vehicle + TBHP group; p<0.001). 
However, a 1 h pretreatment with ERK1/2 or JNK inhibitors (5 µM U0126 and 5 µM 
SP600125, respectively), did not significantly alter TBHP-stimulated IL-6 release (IL-6 
concentrations remained increased compared with their respective control; p<0.05). 
These data suggest that TBHP-stimulated IL-6 release is mediated by p38 MAPK activity 
and fails to support a role for the ERK 1/2 or JNK pathways.   
NF-κB reporter gene activity 
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To determine whether exposure to TBHP stimulates NF-κB activity, HTR-
8/SVneo cells were transfected with NF-κB reporter gene and treated with different 
concentrations of TBHP for 24 h. Exposure to 50 µM TBHP resulted in 6.7 fold 
increased reporter activity compared to the untreated control (Figure 4.5A; p=0.002), a 
level similar to the response elicited by 100 ng/ml LPS (7.1 fold; p=0.001), included as a 
positive control. We also examined whether NF-κB activity depended on p38 MAPK by 
pretreating with 10 µM PD169316 for 1 h.  Inhibition of p38 MAPK failed to inhibit 
TBHP-stimulated NF-κB reporter gene activity (Figure 4.5B).  
DISCUSSION 
The role of ROS in stimulation of parturition-associated pathways in cells of 
human gestation has been scarcely studied. The purpose of the present study was to 
examine the effect of a prototypical pro-oxidant chemical, TBHP, on IL-6 production in a 
human gestational cell model. Increased IL-6 is consistently observed in the amniotic 
fluid and cervicovagnial fluid of women who deliver preterm (Wei et al. 2010).  
Here, we found that TBHP stimulated a significant 2.3 fold increase in IL-6 
production from HTR-8/SVneo cells, a human placental trophoblast cell line. This 
magnitude of IL-6 change is similar to the 2 to 3 fold changes that occur with term labor 
in amniotic fluid and extraplacental membrane tissue (Laham et al. 1996). Several studies 
suggest that oxidative insult stimulates increases in parturition-associated cytokines. Of 
relevance to this study, term placental explants exposed to superoxide or hypoxia-
reoxygenation injury produce cytokines TNFα (Coughlan et al. 2004; Hung et al. 2004), 
IL-1β (Cindrova-Davies et al. 2007), and IL-1α, but not IL-6 (Malek et al. 2001). 
Differences in the milleu of cytokines released from placental explants compared to the 
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results found here may be due to the nature of the oxidant used or differences in 
experimental models. This is the first study to identify IL-6 release in response to 
oxidative insult in human gestational cells.  
The prototype chemical pro-oxidant used in this study, TBHP, undergoes an iron-
catalyzed reaction to produce peroxyl and alkoxyl radicals (Van der Zee et al. 1989). In 
rat hepatocytes, the iron chelator DFO decreased ROS produced as a result of exposure to 
TBHP, thereby inhibiting arachidonic acid release from the cell membrane (Martı́n et al. 
2001) and mitochondrial permeability transition (Nieminen et al. 1997). Similar 
cytoprotective roles for DFO have been reported with TBHP in other cell types 
(Kruidering et al. 1997; Sogabe et al. 1996; Yajima et al. 1995). Although we did not 
directly measure free radical production by TBHP here, we found that DFO pretreatment 
inhibited TBHP-stimulated IL-6 release from HTR-8/SVneo cells. Similarly, cotreatment 
with the antioxidants DPPD or BHA (Clark et al. 1985; Sogabe et al. 1996; Verhagen et 
al. 1991) decreased IL-6 release from HTR-8/SVneo cells, although inhibition was 
incomplete compared with DFO pretreatment. Taken together our data suggest TBHP-
stimulated IL-6 release is due to ROS formation. Because DPPD and BHA are effective 
inhibitors of lipid peroxidation (Clark et al. 1985; Sogabe et al. 1996; Verhagen et al. 
1991), our data suggest dependence, at least in part, on lipid peroxidation. A more 
thorough examination of the nature of the TBHP-stimulated IL-6 response, however, is 
warranted to elucidate the relative contributions of lipid peroxidation-dependent and -
independent mechanisms that contribute to cytokine signaling.  
Previously, we showed that TBHP stimulated PGE2 release from HTR-8/SVneo 
cells and that the PGE2 release was inhibited by cotreatment with the PTGS inhibitor 
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indomethacin (see Chapter 3). In the present study, we evaluated the contribution of 
PGE2 to TBHP-stimulated IL-6 because PGE2 stimulates release of IL-6 in human 
chondrocytes (Wang et al. 2010) and increases cytokines IL-8, IL-10, and monocyte 
chemotactic peptide-1 (MCP-1) in perfused human placentae (Denison et al. 1998). 
Additionally, HTR-8/SVneo cells produce EP receptors 1, 2, 3, and 4 (Nicola et al. 2005), 
enabling them to respond to prostaglandins. However, TBHP-stimulated IL-6 release was 
not affected by cotreatment with indomethacin. Our data, therefore, fail to support a role 
for PGE2 in the TBHP-stimulated IL-6 response and indicate that the stimulated IL-6 
release is dependent on a different mechanism.  
MAPK signaling pathways are critical for the release of proinflammatory 
cytokines (Zhang and Dong 2005). Here, we found that TBHP-stimulated IL-6 release 
was blocked using the p38 MAPK inhibitor PD169316. Consistent with our findings, 
inhibition of p38 MAPK blocked early release of TNF-α and IL-1β from human placental 
explants exposed to hypoxia-reoxygenation injury (Cindrova-Davies et al. 2007). 
Dependence of IL-6 release on TBHP-stimulated p38 activity is consistent with the 
known sensitivity of p38 MAPK to the cellular redox environment (McCubrey et al. 
2006). In contrast, our data do not support a role for ERK 1/2 or JNK in TBHP-
stimulated IL-6 release from the HTR-8/SVneo cells, although ERK 1/2, JNK, and p38 
are activated in the murine uterus during parturition (Takanami-Ohnishi et al. 2001) and 
phosphorylation of key kinases in these MAPK pathways is increased in uterine cervical 
stroma of women after delivery at term (Wang and Stjernholm 2007). The concentrations 
of ERK1/2 inhibitor (5 µM U0126) and JNK (5 µM SP600125) used in the present study 
were reported to inhibit TNFα-induced activation of respective MAPK pathways in HTR-
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8/SVneo cells (Renaud et al. 2009), yet we failed to observe significant decreases in 
TBHP-stimulated IL-6. Because of the limitations of pharmacologic inhibitors, future 
studies could use a genetic approach to deplete MAPK pathways, and thereby further 
assess involvement of these pathways in TBHP-mediated signaling. 
NF-κB is a transcription factor critical to the regulation of inflammatory pathway 
gene expression (Vallabhapurapu and Karin 2009). Important to parturition, NF-κB 
mediates gestational cell PTGS2 and cytokine expression in response to stimulation with 
LPS and cytokines (Ackerman et al. 2008; Keelan et al. 2009; Yan et al. 2002). Increased 
NF-κB binding activity and nuclear translocation is found in gestational tissues during 
term and preterm labor (Chapman et al. 2004; Vora et al. 2010). In addition, 
pharmacologic inhibition of NF-κB delays onset of labor in a mouse model of premature 
labor (Condon et al. 2004). The latter reports are consistent with the 6.7-fold increase in 
reporter activity found in HTR-8/SVneo cells exposed to 50 µM TBHP for 24 h. 
Although we found associated increases in IL-6, we did not assess a causal relationship 
between stimulated NF-κB activity and IL-6. Exposure of intestinal epithelial cells to IL-
6 stimulates NF-κB-mediated increases in adhesion molecule expression (Wang et al. 
2003). On the other hand, NF-κB transactivation induces IL-6 synthesis following LPS, 
interferon-γ (IFNγ), and TNFα treatment in a human macrophage cell line (Libermann 
and Baltimore 1990). Therefore, further experiments are needed to determine 
interdependence of IL-6 on NF-κB or vice versa.  
Our data failed to support a role for p38 MAPK in induction of NF-κB reporter 
activity. For the NF-κB reporter experiments, we used 10 µM PD169316, the same 
concentration that was effective in inhibiting the TBHP-stimulated IL-6 release. NF-κB-
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dependent transcription of cytokines in LPS-stimulated neutrophils is ablated when a 
different p38 MAPK inhibitor, SB203580, was added to cultures, suggesting p38 MAPK 
may directly or indirectly activate NF-κB (Nick et al. 1999). Other studies suggest that 
p38 MAPK activity and NF-κB cooperate in the nucleus to stimulate transcriptional 
activity (Bergmann et al. 1998; Read et al. 1997; Saccani et al. 2002). As such, we 
expected that the p38 MAPK inhibitor PD169316 would abrogate TBHP-stimulated NF-
κB activity. Inconsistencies in the results of these studies might be due to differences in 
physiology of cell types or the stimuli used to initiate p38 MAPK and NF-κB activity. An 
alternative mechanism responsible for stimulation of NF-κB activity might include direct 
TBHP-stimulated redox-mediated phosphorylation of the NF-κB regulating chaperone, 
inhibitor of κB (IκB), thereby promoting nuclear shuttling (Morgan and Liu 2011; 
Oliveira-Marques et al. 2009). Additionally, TBHP has been shown to induce NF-κB 
activity, purportedly through its lipid peroxidation activity (Bowie et al. 1997). Further 
studies are needed to elucidate mechanisms by which TBHP contributes to stimulation 
NF-κB. 
A potential limitation of our study is the use of a first trimester extravillous 
trophoblast cell line, HTR-8/SVneo. Though the HTR-8/SVneo cells have similar 
phenotypes as primary extravillous trophoblast cells (Biondi et al. 2006; Jovanović and 
Vićovac 2009; Jovanović et al. 2010; Nicola et al. 2005; Nicola et al. 2008) and are 
genetically stable (Drennan et al. 2010), a recent study has shown that the epigenetic map 
(Novakovic et al. 2011) of these cells differs from primary cells. Perhaps more 
importantly, given that this cell line is derived from placenta in the first trimester, these 
cells may respond differently than gestational cells isolated during periods more relevant 
 98 
to preterm birth. Nevertheless, HTR-8/SVneo cells respond by producing the 
proinflammatory cytokine IL-6, similar to cytokines produced by term placental explants 
exposed to ischemia-reoxygenation (Cindrova-Davies et al. 2007). Primary cell cultures 
and tissue cultures from human placentae later in pregnancy may provide more directly 
relevant models for preterm parturition. These experiments, however, are beyond the 
scope of the present investigation. 
As an extravillous trophoblast cell line derived from first trimester human 
placenta, the HTR-8/SVneo cell results may have relevance to early events of pregnancy. 
Importantly, dysfunctional extravillous trophoblast migration and subsequent impaired 
spiral artery transformation has been linked to adverse pregnancy outcomes including 
preeclampsia (Merviel et al. 2004; Wang et al. 2009) and preterm birth (Kim et al. 2002; 
Kim et al. 2003). However, the role of IL-6 in placentation is unclear. Treatment of 
extravillous trophoblasts with IL-6 induces trophoblast migration (Jovanović and 
Vićovac 2009), suggesting an important function for IL-6 in physiologic placental 
development. However, treatment of extravillous trophoblast cells (Anton et al. 2012; 
Kim et al. 2005) with LPS, which stimulated IL-6 release, also resulted in decreased 
trophoblast migration. Therefore the potential relevance of the TBHP-stimulated IL-6 
release for trophoblast migration is unclear.  
Limited studies suggest that environmental exposures activate pathways related to 
parturition. For example, cigarette smokers are more likely to deliver preterm 
(Cnattingius 2004) and have increased systemic biomarkers for oxidative damage and 
inflammation (Yanbaeva et al. 2007). Similarly, increased organochlorine pesticide 
exposures are associated with increased damage markers and increased rates of preterm 
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delivery (Pathak et al. 2010). The present study provides a potential mechanistic link that 
explains the associations between environmental exposures and preterm birth. This study 
is the first, to our knowledge, to use a chemical oxidant on a human trophoblast-derived 
cell line to assess parturition-related end points, namely cytokine release.  
In summary, we have shown that exposure to the chemical oxidant TBHP 
stimulated release of the parturition-associated cytokine IL-6 in a human placental 
trophoblast-derived cell line. Importantly, induction of this cytokine plays an important 
role in the induction of pathways involving prostaglandins, matrix metalloproteinases, 
and other parturition-mediating cytokines. As such, ROS may be an important mediator 
in the initiation of these events. These findings are novel in that IL-6, which has been 
consistently linked to preterm birth (Wei et al. 2010), has not been previously identified 
as regulated by ROS in human cells of gestation. Furthermore, we identified p38 MAPK 
as critical to the TBHP-stimulated IL-6 response, suggesting p38 may be an important 
signaling node in trophoblast cell responses to oxidative insult. Because many 
environmental chemicals associated with preterm birth also increase ROS, these findings 
suggest a mechanism by which exposure to environmental contaminants may contribute 
to increased risk for preterm birth.  
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Figure 4.1. TBHP-stimulated IL-6 release. HTR-8/SVneo cells were exposed to 0, 
12.5, 25, or 50 µM TBHP for 4, 8, or 24 h. LPS (100 ng/ml) was included as a positive 
control. IL-6 release into culture medium was measured using ELISA. Data are presented 
as mean ± SEM from 3 experiments. *, Significantly different compared with the time-




Figure 4.2. Effect of antioxidant treatment on TBHP-stimulated IL-6 release. A) 
HTR-8/SVneo cells were pretreated with 1mM DFO for 1 h, the DFO-containing 
medium was removed, and then cells were treated with 50 µM TBHP or fresh medium 
alone for 24 h. Data are presented as mean ± SEM of 4 experiments. *, Significantly 
different compared with the untreated controls (p<0.001). #, Significantly different 
compared with the samples treated with TBHP alone (p<0.001).  B) Cells were cotreated 
with 50 µM TBHP and 1 µM BHA, 25 µM DPPD, or vehicle (0.1% DMSO; control) for 
24 h. Filled bars represent treatment with TBHP and unfilled bars represent cells not 
treated with TBHP. Data are presented as mean ± SEM ± SEM of 3 experiments. *, 
Significantly different compared with co-treatment matched control (p<0.001). #, 




Figure 4.3. Effect of the PTGS inhibitor indomethacin (Indo) on TBHP-stimulated 
IL-6 release. HTR-8/SVneo cells were treated with 50 µM TBHP in the presence or 
absence of 10 µM indomethacin for 24 h. Cultures exposed to 0.1% DMSO were vehicle 
controls for indomethacin. Filled bars represent treatment with TBHP and unfilled bars 
represent cells not treated with TBHP. Bars represent mean ± SEM IL-6 concentration in 




Figure 4.4. Effect of MAPK inhibitors on TBHP-stimulated IL-6 release. HTR-
8/SVneo cells were pretreated with vehicle (0.1% DMSO; control), 10 µM PD169316 
(p38 MAPK inhibitor), 5 µM U0126 (ERK 1/2 inhibitor), 5 µM SP600125 (JNK 
inhibitor) or medium alone for 1 h, and then exposed to 50 µM TBHP for 24 h. IL-6 
release into culture medium was assessed by ELISA. Filled bars represent treatment with 
TBHP and unfilled bars represent cells not treated with TBHP. Data are presented as 
mean ± SEM of 3 experiments, performed in triplicate. *, Significantly different 
compared with the control that received the same pretreatment (p<0.05). #, Significantly 




Figure 4.5. Effect of TBHP and p38 MAPK inhibitor on NF-κB reporter activity. 
HTR-8/SVneo cells were transfected with NF-κB reporter gene constructs and allowed an 
18 h recovery time. A) After transfection, cells were treated with 0, 12.5, 25, or 50 µM 
TBHP for 24 h. LPS (100 ng/ml) was included as a positive control. B) Cells were 
pretreated with 10 µM PD169316 (p38 MAPK inhibitor) or vehicle (0.4% DMSO) for 1 
h, pretreatments were removed, and cells were then treated with 50 µM TBHP for 24 h. 
Dual luciferase assays were performed to assess NF-κB activation. Data are presented as 
fold change (mean ± SEM) over the untreated controls from 3-4 experiments. Relative 
light units (RLU) measured from Firefly luciferase activity were divided by RLU from 
the internal control, Renilla luciferase, then fold changes were calculated relative to the 
non-treated samples (control) in A or vehicle control in B. *, Significantly different 
compared with the untreated controls (p<0.05).   
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CHAPTER 5  
DISCUSSION 
This thesis explores mechanisms by which cellular reactive oxygen species (ROS) 
may stimulate parturition-associated pathways within placental cells. Whereas roles of 
prostaglandins, cytokines, and apoptosis in parturition have been described, the effect of 
ROS on these parturition pathways is unclear. Several studies support ROS involvement 
in parturition pathways (Buhimschi et al. 2003; Lappas et al. 2003; Matsumoto et al. 
2013), and evidence of cellular damage due to ROS has been associated with shortened 
gestation length (Comporti et al. 2004; Mocatta et al. 2004; Pathak et al. 2010; Stein et al. 
2008) and labor at term (Mocatta et al. 2004; Mongelli et al. 1997; Rogers et al. 1998; 
Yaacobi et al. 1999). 
We demonstrated that tert-butyl hydroperoxide (TBHP), a prototypical chemical 
oxidant, stimulated release of prostaglandin (PG) E2, the cytokine interleukin (IL)-6, and 
caspase activity in the human placental cell line HTR-8/SVneo. This is the first study to 
identify stimulation of IL-6 from a human gestational tissue in response to an oxidative 
insult. In addition, whereas Cindrova-Davies et al. (2007) identified prostaglandin 
endoperoxide synthase (PTGS)-2, an enzymatic constituent within the prostaglandin 
synthetic process, as a target induced by hypoxia-reoxygenation injury, this study is the 
first to identify PGE2 as a potential prostaglandin mediator produced by placental tissues 
in response to a chemical that produces ROS. This study is also consistent with models of 
placental hypoxia-reoxygenation, in observing stimulation of apoptosis-related pathways 
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as a response to oxidative injury (Cindrova-Davies et al. 2007a; Hung et al. 2002). A 
potential caveat to earlier models that employed hypoxia-reoxygenation to generate ROS 
is that the quantitation of ROS and overall physiologic relevance may be difficult to 
decipher. In contrast, this study used a precise amount of ROS-producing chemical in 
each experiment, facilitating comparisons between our results and studies using other 
ROS. We observed that TBHP generated parturition-related responses while also 
generating modest changes in the cellular redox potential, suggesting that these endpoints 
can be stimulated even in the absence of overt oxidative damage.  
Research presented in this thesis identifies p38 MAPK as a critical mediator in the 
induction of prostaglandin and cytokine release. This finding is in accordance with in 
vitro explant studies with human extraplacental membrane and human placenta (Lappas 
et al. 2007; Lappas et al. 2011; Wang and Stjernholm 2007) and known responsiveness of 
p38 MAPK to cellular redox regulation (McCubrey et al. 2006). Taken together, these 
studies suggest p38 MAPK may represent a viable target with therapeutic potential for 
women who are at risk for preterm birth. Another potential therapy may include 
supplementation with antioxidants. However, a recent meta-analysis suggests that 
antioxidant vitamins C and E have no significant effect on preterm birth as an outcome in 
randomized control trials (Dror and Allen 2012), suggesting that antioxidant therapy 
alone may be insufficient as an intervention for general populations.  
Based on our results, we propose the model shown in Figure 5.1. In this model, 
TBHP promotes formation of ROS within the placental cell, supported by findings that 
TBHP-stimulated parturition-related endpoints were inhibited by the antioxidants 
butylated hydroxanisole (BHA) and diphenyl phenylenediamine (DPPD). Inhibition of 
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downstream responses by the iron chelator deferoxamine further suggests that TBHP 
forms iron-dependent alkoxyl and peroxyl radicals, as previously described (Van der Zee 
et al. 1989). Resultant ROS may then stimulate phosphorylation, and thereby activation, 
of p38 MAPK, as supported by TBHP-stimulated p38 phosphorylation in the placental 
cells. Because the p38 MAPK inhibitor PD169316 blocked the prostaglandin synthetic 
responses, 38 MAPK kinase activity may be driving PTGS2 transcription and subsequent 
PGE2 production. The PTGS2 gene contains consensus sequences of a number of 
transcription factors, including activator protein (AP)-1, whose activation is kinase 
dependent (Chun and Surh 2004).  
Because antioxidants BHA, DPPD, deferoxamine and the p38 MAPK inhibitor 
PD169316 all blocked TBHP-stimulated IL-6 release, we propose that ROS-dependent 
p38 MAPK also drives placental cell production of IL-6 (Figure 5.1). Temporally, PGE2 
production preceded that of IL-6 suggesting a potential stimulatory effect of PGE2 on IL-
6. Although PGE2 can stimulate cytokine release from human placental tissue (Denison et 
al. 1998), our data did not support this finding. This may be because the levels of PGE2 
produced by HTR-8/SVneo cells were relatively low, and thus did not meet the threshold 
to have an effect. Alternatively, this could be because these pathways are simply not 
linked in this situation. On the other hand, the effects of ROS may outweigh any effect 
PGE2 may have in stimulating IL-6 or apoptosis, this inhibiting PGE2 production would 
appear to have no effect.  
Treatment with TBHP also increased NF-κB reporter transactivation at the same 
time point it stimulated IL-6, suggesting a possible causal link between ROS activation of 
NF-κB and increased IL-6 release (Figure 5.1). Indeed, like PTGS2, the gene for IL-6 
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contains NF-κB consensus sequences (Libermann and Baltimore 1990). Similar to 
MAPK activation, stimulation of NF-κB activity may occur by redox-mediated 
phosphorylation of the NF-κB regulating chaperone, inhibitor of κB (IκB) (Morgan and 
Liu 2011; Oliveira-Marques et al. 2009). Although MAPK signaling can stimulate NF-κB 
transactivation (Nick et al. 1999), our data did not support this mechanism.  
We suggest that ROS drives caspase-mediated apoptosis (Figure 5.1). Although 
we did not measure apoptosis per se, TBHP-stimulated caspase activation was inhibited 
by deferoxamine. One possible mechanistic explanation for this finding is that TBHP 
causes HTR-8/SVneo DNA damage (Tetz et al. 2013) and may thusly induce subsequent 
p53-dependent activation of apoptosis pathways (Wyllie 2010). Although previous 
reports suggest roles for PGE2 and caspase activation in apoptosis (Ackerman and 
Murdoch 1993; Fard et al. 2012; Takadera et al. 2004), and p38 MAPK (Cindrova-Davies 
et al. 2007a; Grethe et al. 2004), our results did not support these mechanisms of 
apoptosis activation in the placental cells. In addition, it is worth noting that caspase 
activity has been reported in quiescent myometrial cells, or, in other words, living, non-
contracting myometrium (Jeyasuria et al. 2009). Therefore, we are cautious in suggesting 
the only interpretation to increased caspase activity is apoptotic cell death. However, we 
did find a concomitant decrease in cell viability with caspase activation.  
The TBHP-stimulated redox responses we observed were relatively modest in 
magnitude. Nonetheless, the apoptosis, prostaglandin, and cytokine responses were 
inhibited by antioxidants, suggesting that TBHP-induced effects are ROS dependent. 
Treatment of HTR-8/SVneo cells with TBHP stimulated increases in cellular oxidized 
glutathione (GSSG) (Figure 5.1) without significant changes in reduced glutathione 
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(GSH). We speculate this may be because peroxides like TBHP (Toussaint et al. 1993) 
can also inhibit glutathione peroxidase, the enzyme responsible for detoxifying TBHP. 
Exposure to TBHP also induced modest reporter activity at the antioxidant response 
element (ARE). This suggests that TBHP may oxidize residues on kelch-like ECH-
associated protein 1 (KEAP1), freeing nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 
to drive transcription at ARE (Motohashi and Yamamoto 2004). Once unobstructed, Nrf2 
then drives antioxidant gene expression, including thioredoxin reductase 1 (TXNRD1) 
(Hintze et al. 2003) and glutaredoxin 2 (GLRX2) (Gallogly et al. 2009), as observed in 
the present study. Taken together, these data may suggest that ROS can activate cellular 
pathways involving prostaglandins, cytokines, and even cell death in the absence of 
major changes in the cell’s redox status. These results are not unheard of; in human 
keratinocytes treated with epidermal growth factor (EGF), redox-sensitive cytosolic 
thioredoxin can be oxidized while the glutathione redox potential remains unchanged 
(Halvey et al. 2005). As such, we speculate that environmental chemicals, which may 
produce a relatively low concentration of ROS, may still alter parturition-promoting 
pathways resulting in an increased risk for prematurity in women. Further studies are 
needed to characterize additional redox-related changes induced by TBHP and identify 
exact molecular targets linking TBHP, ROS, and parturition-associated endpoints.  
 We recognize that there are limitations to this study. We are cautious in 
interpreting results from cell lines, because the process of immortalization itself and 
subsequent passaging for extended periods can lead to genetic drift that may not 
adequately model phenotypes (Kaur and Dufour 2012). We also recognize that HTR-
8/SVneo cells are derived from first trimester, and may not be phenotypically similar to 
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cells that contribute to preterm parturition. As such, repeating these experiments in 
primary cells from later in gestation is logical next step for this research. However, as the 
HTR-8/SVneo cells are derived from first trimester placenta, results presented in this 
thesis may have relevance to early events of pregnancy and its subsequent adverse 
outcomes. Prostaglandins (Biondi et al. 2006; Horita et al. 2007; Nicola et al. 2005; 
Nicola et al. 2008a; Nicola et al. 2008b) and cytokines (Jovanović and Vićovac 2009) are 
both modulators of placental development, dysregulation of which has been implicated in 
preeclampsia (Merviel et al. 2004; Wang et al. 2009)  
This study provides a potential mechanistic explanation by which environmental 
pollutant chemicals may increase risk for preterm birth. That is, many environmental 
chemicals that have been associated with shortened gestation length (Jelliffe-Pawlowski 
et al. 2006; Meeker et al. 2009; Pathak et al. 2009) have also been shown to stimulate 
ROS or oxidative stress (Ercal et al. 2001; Pathak et al. 2010; Tetz et al. 2013). Toxicant-
derived ROS within the gestational compartment may then be responsible for driving 
parturition-associated pathways involving prostaglandins, cytokines, and apoptosis. 
Therefore, experimental studies seeking to examine the link between toxicant exposure 
and early birth in animal models, may choose to examine toxicant effects on ROS and 
parturition-promoting pathways in gestational tissues. Furthermore, by providing a 
potential mechanistic link between exposure and outcome, we now have a hypothesis to 
test in further human-based work. Future epidemiologic studies examining the link 
between toxicant exposure and preterm birth, may also want to include markers for 
damage due to ROS including lipid peroxidation or DNA damage in tissue, blood, urine, 
or amniotic fluid to add a mechanistic component to their studies. In addition, studies 
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involving antioxidant administration in pregnant women may choose to examine 
environmental chemical exposure status as a potential modifier of risk of adverse 
outcomes. 
Bacterial infection is recognized as a leading cause of preterm labor. In addition 
to direct signaling to produce proinflammatory cytokines (Akira and Takeda 2004), toll-
like receptor (TLR) activation by bacterial products induces NADPH oxidase activity. 
This enzyme is responsible for making ROS that not only kill bacteria (Laroux et al. 
2005), but may also contribute to cell signaling that promotes parturition. Similarly, ROS 
may be contributing to the progression of normal parturition. Contractions of the 
myometrium during labor can compress blood vessels and lead to intermittent uterine 
blood supplies (Janbu and Neshetm 1987), lending potential for hypoxia-reoxygenation 
injury during labor (Cindrova-Davies et al. 2007b). Resultant ROS may then further 
contribute to labor in a feed-forward manner. Once labor is started, ROS are produced in 
response to hypoxia-reoxygenation, which can then further stimulate prostaglandin and 
cytokine responses.  
In summary, we have identified a potential contributing mechanism for the 
induction normal and preterm labor. Whether produced as a result of environmental 
chemical exposure, bacterial infection, or hypoxia-reoxygenation injury, this thesis shows 
that ROS can activate cytokines, prostaglandins, and apoptosis within the gestational 
compartment. Each of these endpoints are critical components to the progression of labor. 
Therefore, further studies examining the causal link between ROS and increased risk for 
early labor are warranted. As a leading cause of infant morbidity and mortality, preterm 
birth is a vexing public health problem whose etiology is not fully understood. By 
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identifying a potential signaling node in the pathophysiology of this event, we have found 
a potential site to modify risk for disease.   
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Figure 5.1. Conceptual model of TBHP effects in placental trophoblast cells. TBHP 
generates ROS in an iron-dependent manner. Resultant ROS drive the phosphorylation, 
and thereby activation, of p38 MAPK. Activity of p38 MAPK stimulates IL-6 release, 
PTGS2 expression, and PGE2 synthesis ROS also induce NF-κB transactivation, which 
may be responsible for IL-6 release. Caspase activity, and subsequent apoptosis, are also 
stimulated by TBHP-generated ROS. Finally, ROS may also be responsible for modest 
changes in GSSG, Nrf2 transactivation, and subsequent expression of the antioxidant 
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Figure A.1. Effect of TBHP on prostaglandin synthetic enzyme expression. Changes 
in mRNA expression of A) PTGS1 and B) PTGES following treatment of HTR-8/SVneo 
cells with 12.5, 25, or 50 µM TBHP for 4, 8, or 24 h. Values represent mean fold changes 




Figure A.2. Effects of inhibitors of prostaglandin synthesis and MAPKs on TBHP-
stimulated caspase 3/7 activity. A) HTR-8/SVneo cells were treated with 50 µM TBHP 
in the presence or absence of 10 µM indomethacin for 8 or 24 h. Cultures exposed to 
0.1% DMSO were vehicle controls for indomethacin. Filled bars represent treatment with 
TBHP and unfilled bars represent cells not treated with TBHP. Bars represent mean ± 
SEM for 2 experiments. We did not observe an inhibitory effect when cotreating with 
indomethacin. B) HTR-8/SVneo cells were pretreated with vehicle (0.1% DMSO; 
control), 10 µM PD169316 (p38 MAPK inhibitor), 5 µM U0126 (ERK 1/2 inhibitor), 5 
µM SP600125 (JNK inhibitor) or medium alone for 1 h, and then exposed to 50 µM 
TBHP for 24 h. We did not observe a significant effect of MAPK inhibitors on TBHP-
stimulated caspase 3/7 activity. Filled bars represent treatment with TBHP and unfilled 
bars represent cells not treated with TBHP. Data are presented as mean ± SEM of 3 





Figure A.3. Effect of TBHP on PGF2α and PGF2α synthetic enzyme expression. A) 
Time course and concentration response for TBHP on PGF2α release into culture medium. 
HTR-8/SVneo cells were treated with 0, 12.5, 25, or 50 µM TBHP for 4, 8, or 24 h. We 
did not observe any significant changes in PGF2α release with cells exposed to TBHP for 
4 h or with exposure to 12.5 µM TBHP at any time point. However, 25 µM TBHP 
stimulated significant increases of 2.3 and 3.5 fold over time-matched controls at 8 and 
24 h (p<0.05). Treatment with 50 µM TBHP stimulated increases of 3.9 and 8.5 fold over 
controls at the same respective time points (p<0.05). Futhermore, the stimulated PGF2α 
response was concentration-dependent, increases with 50 µM TBHP exposure were also 
statistically different from cells treated with 25 µM TBHP (p<0.05). B) Effect of 
indomethacin (Indo) on TBHP stimulated PGF2α release. To assess dependency of PGF2α 
release on PTGS activity, we cotreated HTR-8/SVneo cells with 50 µM TBHP (shown in 
gray) and vehicle (0.1% DMSO) or 10 µM indomethacin. All of the TBHP treated cells 
were significantly increased over their cotreatment matched controls (p<0.05). Among 
the TBHP treated cells, there was no statistically significant difference between the 
indomethacin and vehicle co-exposed. C) Effect of TBHP on prostaglandin F synthase 
enzyme, AKR1C3. HTR-8/SVneo cells were treated with 12.5, 25, or 50 µM TBHP for 4, 
8, or 24 h. TBHP did not stimulate any significant changes in AKR1C3 mRNA at 4 or 24 
h. At 8 h, 50 µM TBHP stimulated a significant 1.5 fold increase in expression (p<0.05). 
Values represent mean ± SEM for 3-6 experiments. *, Statisically significant compared to 
time-matched controls (p<0.05). #, Statistically significant compared to time-matched 25 
µM TBHP treated cells (p<0.05). 
